Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2006

Additional information has come to light in the past year, both corroborating the major positive effect these drugs have had in rheumatoid arthritis (RA), psoriatic arthritis (PsA), ankylosing spondylitis (AS), and other rheumatic diseases, and further documenting adverse events. [...]an update of t...

Full description

Saved in:
Bibliographic Details
Published inAnnals of the rheumatic diseases Vol. 65; no. suppl 3; pp. iii2 - iii15
Main Authors Furst, D E, Breedveld, F C, Kalden, J R, Smolen, J S, Burmester, G R, Emery, P, Keystone, E C, Schiff, M H, van Riel, P L C M, Weinblatt, M E, Weisman, M H
Format Journal Article Conference Proceeding
LanguageEnglish
Published London BMJ Publishing Group Ltd and European League Against Rheumatism 01.11.2006
BMJ
Elsevier Limited
BMJ Group
Subjects
Abatacept
ACR
American College of Rheumatology
ankylosing spondylitis
Antirheumatic Agents - adverse effects
Antirheumatic Agents - therapeutic use
Arthritis, Psoriatic - drug therapy
Arthritis, Rheumatoid - drug therapy
Biological and medical sciences
CHF
Clinical medicine
congestive heart failure
Consensus Statement
DAS
Disease
Disease Activity Score
disease modifying antirheumatic drug
Diseases of the osteoarticular system
DMARD
Drug dosages
guideline
HAQ-DI
Health Assessment Questionnaire disability index
Humans
IL-1ra
immunity
Immunization
Immunoconjugates - adverse effects
Immunoconjugates - therapeutic use
Immunologic Factors - adverse effects
Immunologic Factors - therapeutic use
Infections
inflammation
Interleukin 1 Receptor Antagonist Protein - adverse effects
Interleukin 1 Receptor Antagonist Protein - therapeutic use
Medical Outcome Survey Short Form 36
Medical sciences
methotrexate
Miscellaneous. Osteoarticular involvement in other diseases
MTX
Pain
Patients
Pharmaceutical industry
PsA
psoriatic arthritis
Rheumatic diseases
Rheumatic Diseases - drug therapy
rheumatoid arthritis
rituximab
SF-36
Spondylitis, Ankylosing - drug therapy
Studies
TNF
TNF blocking
TNF inhibitors
Tumor Necrosis Factor-alpha - antagonists & inhibitors
Tumor necrosis factor-TNF
tumour necrosis factor
VAS
visual analogue scale
Europe
Rheumatism
Treatment
Diseases of the osteoarticular system
Biological agent
Online AccessGet full text
ISSN0003-4967
1468-2060
DOI10.1136/ard.2006.061937

Cover

Abstract Additional information has come to light in the past year, both corroborating the major positive effect these drugs have had in rheumatoid arthritis (RA), psoriatic arthritis (PsA), ankylosing spondylitis (AS), and other rheumatic diseases, and further documenting adverse events. [...]an update of the previous consensus statement is appropriate. 1 The consensus statement is annotated to document the credibility of the data supporting it as much as possible. Because these agents are not free of toxicity, patients or their representatives should be provided with information about potential risks and benefits so that they may give informed consent for treatment.
AbstractList Additional information has come to light in the past year, both corroborating the major positive effect these drugs have had in rheumatoid arthritis (RA), psoriatic arthritis (PsA), ankylosing spondylitis (AS), and other rheumatic diseases, and further documenting adverse events. [...]an update of the previous consensus statement is appropriate. 1 The consensus statement is annotated to document the credibility of the data supporting it as much as possible. Because these agents are not free of toxicity, patients or their representatives should be provided with information about potential risks and benefits so that they may give informed consent for treatment.
Author Breedveld, F C
Smolen, J S
Burmester, G R
Emery, P
Keystone, E C
Schiff, M H
Weinblatt, M E
Weisman, M H
Furst, D E
Kalden, J R
van Riel, P L C M
AuthorAffiliation G R Burmester , Department of Rheumatology, and Clinical Immunology, Charité Hospital, Berlin, Germany
P L C M van Riel , University Nijmegen Medical Centre, Nijmegen, the Netherlands
J R Kalden , Department of Internal Medicine III, Institut for Clinical Immunology, University of Erlangen‐Nuremberg, Erlangen Germany
J S Smolen , Institute of Rheumatology, Clinic for Internal Medicine III, Vienna General Hospital, Vienna, Austria
M E Weinblatt , Brigham and Women's Hospital, Boston, MA, USA
P Emery , Leeds University, Department of Rheumatology, Leeds General Infirmary, Leeds, UK
M H Weisman , Cedar Sinai Hospital, Los Angeles, CA, USA
E C Keystone , Department of Rheumatology, Mount Sinai Hospitial, Toronto, Canada
D E Furst , David Geffen School of Medicine, Los Angeles, CA, USA
F C Breedveld , Department of Rheumatology, Leiden University Medical Centre, Leiden, the Netherlands
M H Schiff , Denver Arthritis Clinic, Denver, CO, USA
AuthorAffiliation_xml – name: M H Schiff , Denver Arthritis Clinic, Denver, CO, USA
– name: G R Burmester , Department of Rheumatology, and Clinical Immunology, Charité Hospital, Berlin, Germany
– name: D E Furst , David Geffen School of Medicine, Los Angeles, CA, USA
– name: F C Breedveld , Department of Rheumatology, Leiden University Medical Centre, Leiden, the Netherlands
– name: M H Weisman , Cedar Sinai Hospital, Los Angeles, CA, USA
– name: P Emery , Leeds University, Department of Rheumatology, Leeds General Infirmary, Leeds, UK
– name: P L C M van Riel , University Nijmegen Medical Centre, Nijmegen, the Netherlands
– name: J S Smolen , Institute of Rheumatology, Clinic for Internal Medicine III, Vienna General Hospital, Vienna, Austria
– name: E C Keystone , Department of Rheumatology, Mount Sinai Hospitial, Toronto, Canada
– name: M E Weinblatt , Brigham and Women's Hospital, Boston, MA, USA
– name: J R Kalden , Department of Internal Medicine III, Institut for Clinical Immunology, University of Erlangen‐Nuremberg, Erlangen Germany
Author_xml – sequence: 1
  givenname: D E
  surname: Furst
  fullname: Furst, D E
  organization: Cedar Sinai Hospital, Los Angeles, CA, USA
– sequence: 2
  givenname: F C
  surname: Breedveld
  fullname: Breedveld, F C
  organization: Cedar Sinai Hospital, Los Angeles, CA, USA
– sequence: 3
  givenname: J R
  surname: Kalden
  fullname: Kalden, J R
  organization: Cedar Sinai Hospital, Los Angeles, CA, USA
– sequence: 4
  givenname: J S
  surname: Smolen
  fullname: Smolen, J S
  organization: Cedar Sinai Hospital, Los Angeles, CA, USA
– sequence: 5
  givenname: G R
  surname: Burmester
  fullname: Burmester, G R
  organization: Cedar Sinai Hospital, Los Angeles, CA, USA
– sequence: 6
  givenname: P
  surname: Emery
  fullname: Emery, P
  organization: Cedar Sinai Hospital, Los Angeles, CA, USA
– sequence: 7
  givenname: E C
  surname: Keystone
  fullname: Keystone, E C
  organization: Cedar Sinai Hospital, Los Angeles, CA, USA
– sequence: 8
  givenname: M H
  surname: Schiff
  fullname: Schiff, M H
  organization: Cedar Sinai Hospital, Los Angeles, CA, USA
– sequence: 9
  givenname: P L C M
  surname: van Riel
  fullname: van Riel, P L C M
  organization: Cedar Sinai Hospital, Los Angeles, CA, USA
– sequence: 10
  givenname: M E
  surname: Weinblatt
  fullname: Weinblatt, M E
  organization: Cedar Sinai Hospital, Los Angeles, CA, USA
– sequence: 11
  givenname: M H
  surname: Weisman
  fullname: Weisman, M H
  organization: Cedar Sinai Hospital, Los Angeles, CA, USA
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18248160$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/17038465$$D View this record in MEDLINE/PubMed
BookMark eNqFkstv1DAQxi1URLeFMzdkCcEBka3tJH5cKqFVeaniIdGqJyzHj10vSbzYSQX_PY6ytNADnCyPf9_MN-M5Agd96C0AjzFaYlzSExXNkiBEl4hiUbJ7YIEryguCKDoAC4RQWVSCskNwlNI2XxHH_AE4xAyVvKL1Any92Bk1WAN16JPt05hgGnKgs_0AQw8bH9qw9lq1UK1zLEEXIhw2Fg7RqmHGHIwbO3Zq8Boan6xKNr2Ek6-H4L5TbbKP9ucxuHh99mX1tjj_-Obd6tV50dSEDIVzBNmaCkG5xoQx0WBOsXGiMo1gzBqDHWUl5rpqNBOV40objgitCLFOleUxOJ3z7sams0ZnW1G1chd9p-JPGZSXf7_0fiPX4VpiJnjJpwTP9wli-D7aNMjOJ23bVvU2jElSLmqBKM_g0zvgNoyxz83lXIzxemo7U0_-9HNj5PfgM_BsD6iUh-ui6rVPtxwnFccUZe5k5nQMKUXrbhEkpxWQeQXkVFPOK5AV9R2F9vlHfZga9-0_dMWs82mwP27KqPhN5tGzWn64XMmruv7ELt9_lleZfzHzTbf9r6lfpUzRWQ
CODEN ARDIAO
CitedBy_id crossref_primary_10_1155_2009_861481
crossref_primary_10_1016_j_clim_2007_08_012
crossref_primary_10_1016_j_berh_2011_06_001
crossref_primary_10_1111_j_1468_3083_2008_02746_x
crossref_primary_10_1136_ard_2008_092668
crossref_primary_10_1183_09031936_00107608
crossref_primary_10_1136_ard_2008_094524
crossref_primary_10_1038_ncprheum0506
crossref_primary_10_3899_jrheum_100136
crossref_primary_10_1111_j_1468_3083_2008_2746_x
crossref_primary_10_1016_j_jbspin_2007_10_001
crossref_primary_10_1155_2014_430134
crossref_primary_10_1136_ard_2008_088401
crossref_primary_10_1177_1478271520083802004
crossref_primary_10_1517_14656566_8_13_2089
crossref_primary_10_1016_j_reuma_2008_10_001
crossref_primary_10_1093_rheumatology_ker290
crossref_primary_10_1016_j_rhum_2007_10_588
crossref_primary_10_1002_art_23144
crossref_primary_10_1016_j_prp_2008_07_002
crossref_primary_10_1517_14656566_8_14_2371
crossref_primary_10_1016_j_rhum_2007_10_622
crossref_primary_10_1016_S0025_7753_11_70007_0
crossref_primary_10_1016_j_riam_2009_04_001
crossref_primary_10_1517_14712590903033919
crossref_primary_10_4078_jkra_2007_14_1_1
crossref_primary_10_1038_ncprheum0761
crossref_primary_10_1002_art_24588
crossref_primary_10_1590_S0365_05962011000400014
crossref_primary_10_1007_s11812_008_0046_0
crossref_primary_10_1517_14656566_8_9_1373
crossref_primary_10_3899_jrheum_090268
crossref_primary_10_1016_j_semarthrit_2010_06_003
crossref_primary_10_1016_j_jinf_2010_02_009
crossref_primary_10_1136_ard_2007_084673
crossref_primary_10_1186_ar2438
crossref_primary_10_1002_art_23529
crossref_primary_10_1136_ard_2007_087106
crossref_primary_10_3899_jrheum_080257
crossref_primary_10_2217_17460816_2_4_353
crossref_primary_10_1016_j_jbspin_2007_10_009
crossref_primary_10_1111_j_1365_2249_2008_03691_x
crossref_primary_10_1111_j_1468_3083_2011_04042_x
crossref_primary_10_1136_ard_2006_054742
crossref_primary_10_1002_art_23682
crossref_primary_10_1007_s10067_010_1532_1
crossref_primary_10_1186_ar2282
crossref_primary_10_1111_j_1365_2249_2008_03804_x
crossref_primary_10_3899_jrheum_080818
crossref_primary_10_1007_BF03087557
crossref_primary_10_1080_09273940802204527
Cites_doi 10.1002/art.20164
10.1007/s10067-005-1122-9
10.1002/art.11017
10.1002/art.21201
10.1172/JCI5857
10.1056/NEJMoa012664
10.1097/01.brs.0000190815.13764.64
10.1136/gut.2005.065417
10.1097/01.ASN.0000114554.67106.28
10.1136/ard.62.suppl_2.ii13
10.1053/sarh.2001.23701
10.1136/ard.61.suppl_2.ii51
10.1111/j.1396-0296.2004.04045.x
10.1001/archderm.139.10.1259
10.1002/art.10699
10.1093/rheumatology/keh479
10.1002/art.10581
10.1097/01.brs.0000141179.58778.6c
10.1002/1529-0131(200112)44:12<2862::AID-ART474>3.0.CO;2-W
10.1378/chest.124.1.177
10.1097/01.mao.0000185082.28598.87
10.1136/gut.2004.040675
10.1136/ard.2004.023176
10.1136/ard.62.suppl_2.ii55
10.2165/00003495-200059060-00010
10.1136/ard.2004.025130
10.1002/art.10231
10.1002/art.20217
10.1136/ard.62.3.280
10.1002/art.11325
10.1002/art.11417
10.1002/art.20335
10.1016/j.rmed.2004.09.001
10.1093/rheumatology/keh617
10.1517/14740338.3.5.391
10.1136/ard.2004.032060
10.2165/00063030-200418020-00005
10.7326/0003-4819-144-12-200606200-00003
10.1097/01.rhu.0000173225.41933.83
10.1136/ard.2005.043166
10.1191/0961203305lu2240rr
10.1038/sj.bmt.1704929
10.1056/NEJMoa041884
10.1002/art.21519
10.1136/ard.2004.024737
10.1136/ard.2004.031187
10.1002/art.11201
10.1056/NEJM200003163421103
10.1056/NEJMoa035075
10.2165/00148581-200406030-00001
10.1016/S0140-6736(00)02530-7
10.1111/j.1365-2133.2005.07067.x
10.1002/art.21468
10.1002/art.20033
10.1093/rheumatology/keh062
10.1136/ard.2004.025692
10.1002/art.11163
10.1136/ard.62.11.1078
10.2165/00003495-200262170-00013
10.1001/archderm.141.1.13
10.1002/ajh.10331
10.1016/S0140-6736(02)08512-4
10.1097/00124743-199906000-00015
10.1056/NEJM200011303432201
10.1093/rheumatology/keh618
10.1056/NEJM200011303432202
10.1002/art.1780391210
10.1093/rheumatology/keh658
10.1002/art.20241
10.1002/art.1780361206
10.1016/S0140-6736(04)15640-7
10.1002/art.20982
10.1080/09546630310020470
10.1136/ard.2004.029272
10.1002/art.10870
10.1002/art.21869
10.1002/art.10876
10.1136/ard.58.2008.i65
10.7326/0003-4819-130-6-199903160-00004
10.1002/art.21306
10.1136/ard.2003.006775
10.1002/art.10583
10.1136/bmj.318.7183.593
10.1016/S1542-3565(04)00238-1
10.1002/art.21563
10.1002/art.20568
10.1016/S0161-6420(03)00406-8
10.1056/NEJMoa011110
10.1002/art.10524
10.1136/jnnp.2004.055434
10.1081/IPH-120037721
10.1002/art.10294
10.4049/jimmunol.172.3.1935
10.2165/00003495-199957060-00014
10.1002/art.10710
10.1002/hep.20206
10.1136/ard.2004.030528
10.1016/j.jaad.2004.05.013
10.1182/blood-2002-03-0985
10.1136/ard.62.11.1116
10.1007/s00296-002-0246-3
10.1086/421494
10.1136/ard.2003.013052
10.1007/s10067-005-0037-9
10.1002/art.20300
10.1002/art.20146
10.1016/S0140-6736(01)05497-6
10.1016/S0140-6736(00)04954-0
10.1093/rheumatology/keg072
10.1136/ard.2003.013961
10.7326/0003-4819-133-9-200011070-00037
10.1097/00005792-200209000-00002
10.1136/ard.62.9.829
10.2165/00002018-200427050-00003
10.1016/j.jaad.2003.05.009
10.1053/j.semarthrit.2003.10.003
10.1111/j.1365-4632.2004.02120.x
10.1111/j.1572-0241.2004.30186.x
10.1136/bmj.317.7152.180
10.1136/ard.2004.020800
10.1136/ard.2004.026617
10.1056/NEJMoa032534
10.1086/383317
10.1016/S0140-6736(94)90632-7
10.1002/art.20769
10.1016/S0889-857X(05)70028-4
10.1136/ard.2004.024182
10.1136/ard.60.90003.iii55
10.1046/j.1365-2133.2001.04089.x
10.1002/art.20576
10.1136/ard.2005.048371
10.1093/rheumatology/40.2.205
10.1136/ard.61.3.283-a
10.1084/jem.20050473
10.1136/ard.62.4.373
10.1002/art.20712
10.1016/S0168-8278(02)00230-1
10.1002/art.10539
10.1002/art.10758
10.1016/j.amjmed.2004.02.039
10.1016/j.jhep.2004.11.025
10.1016/j.jpeds.2004.12.022
10.1002/art.20904
10.1002/art.1780270403
10.1056/NEJMoa030409
10.1055/s-2002-35412
10.1016/0002-9343(91)90667-M
10.1001/archderm.141.9.1167-b
10.1016/j.jaad.2005.04.035
10.1002/art.20953
10.1016/S0140-6736(02)08215-6
10.1002/art.511
10.1046/j.1365-2133.2001.04092.x
10.1136/ard.58.2008.i61
10.1002/1529-0131(200112)44:12<2933::AID-ART482>3.0.CO;2-Y
10.1086/424455
10.1097/00003246-199707000-00010
10.7326/0003-4819-143-12-200512200-00019
10.1136/ard.2003.010967
10.1053/gast.2001.22556
10.1136/ard.62.9.817
10.1002/art.20711
10.1002/art.20299
10.1002/art.10308
10.1056/NEJMoa020888
10.1002/art.11204
10.1002/art.10781
10.1002/art.1780380507
10.1002/1529-0131(200110)44:10<2371::AID-ART401>3.0.CO;2-W
10.1186/1471-2474-4-19
10.1086/430000
10.1002/art.20763
10.1016/S0167-5273(02)00470-9
10.3310/phr06120
10.1185/030079903125004286
10.1002/art.21061
10.1016/j.jpeds.2004.08.001
10.1056/NEJMoa050524
10.1136/ard.43.2.128
10.1002/art.11218
10.1002/1529-0131(199809)41:9<1552::AID-ART5>3.0.CO;2-W
10.1002/art.10671
ContentType Journal Article
Conference Proceeding
Copyright Copyright 2006 by Annals of the Rheumatic Diseases
2006 INIST-CNRS
Copyright: 2006 Copyright 2006 by Annals of the Rheumatic Diseases
Copyright © 2006 BMJ Publishing Group Ltd & European League Against Rheumatism
Copyright_xml – notice: Copyright 2006 by Annals of the Rheumatic Diseases
– notice: 2006 INIST-CNRS
– notice: Copyright: 2006 Copyright 2006 by Annals of the Rheumatic Diseases
– notice: Copyright © 2006 BMJ Publishing Group Ltd & European League Against Rheumatism
DBID BSCLL
AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88E
88I
8AF
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
BTHHO
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9-
K9.
LK8
M0R
M0S
M1P
M2P
M7P
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
Q9U
7X8
5PM
DOI 10.1136/ard.2006.061937
DatabaseName Istex
CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection (ProQuest)
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Science Database (Alumni Edition)
STEM Database
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
BMJ Journals
ProQuest One Community College
ProQuest Central
Proquest Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
Consumer Health Database
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
Consumer Health Database (ProQuest)
Health & Medical Collection (Alumni)
Medical Database
Science Database
Biological Science Database (ProQuest)
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest AP Science
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Family Health (Alumni Edition)
ProQuest Central China
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Science Journals (Alumni Edition)
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest Science Journals
ProQuest Family Health
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
BMJ Journals
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList ProQuest Central Student
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: http://www.proquest.com/pqcentral?accountid=15518
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1468-2060
EndPage iii15
ExternalDocumentID PMC1798383
4008408651
17038465
18248160
10_1136_ard_2006_061937
ark_67375_NVC_X55P7VJQ_X
annrheumdis
Genre Consensus Development Conference
Journal Article
GeographicLocations Europe
GeographicLocations_xml – name: Europe
GroupedDBID ---
.55
.GJ
.VT
169
23M
2WC
39C
3O-
4.4
40O
53G
5GY
5RE
5VS
6J9
7X7
7~S
88E
88I
8AF
8FE
8FH
8FI
8FJ
8R4
8R5
AAHLL
AAKAS
AAOJX
AAWJN
AAWTL
AAXUO
ABAAH
ABJNI
ABKDF
ABMQD
ABOCM
ABTFR
ABUWG
ABVAJ
ACGFO
ACGFS
ACGOD
ACGTL
ACHTP
ACMFJ
ACOAB
ACOFX
ACPRK
ACQSR
ACTZY
ADBBV
ADCEG
ADFRT
ADUGQ
ADZCM
AEKJL
AENEX
AFKRA
AFWFF
AGQPQ
AHMBA
AHNKE
AHQMW
AJYBZ
AKKEP
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ASPBG
AVWKF
AZFZN
AZQEC
BAWUL
BBNVY
BENPR
BHPHI
BKNYI
BLJBA
BOMFT
BPHCQ
BTFSW
BTHHO
BVXVI
C1A
C45
CAG
CCPQU
COF
CS3
CXRWF
DIK
DWQXO
E3Z
EBS
EJD
F5P
FDB
FYUFA
GNUQQ
H13
HAJ
HCIFZ
HMCUK
HYE
HZ~
IAO
IEA
IHR
INH
INR
IOF
ITC
J5H
K9-
KQ8
L7B
LK8
M0R
M1P
M2P
M7P
N9A
NTWIH
NXWIF
O9-
OK1
OVD
P2P
PHGZT
PQQKQ
PROAC
PSQYO
Q2X
R53
RHI
RMJ
RPM
RV8
RWL
RXW
TAE
TEORI
TR2
UAW
UKHRP
UYXKK
V24
VM9
VVN
W2D
W8F
WH7
WOQ
X6Y
X7M
YFH
YOC
YQY
ZGI
ZXP
0R~
3V.
BSCLL
FRP
IGG
RHF
AAFWJ
AALRI
AAYXX
CITATION
PHGZM
IQODW
PJZUB
PPXIY
PQGLB
CGR
CUY
CVF
ECM
EIF
NPM
PKN
7XB
8FK
K9.
PKEHL
PQEST
PQUKI
PRINS
Q9U
7X8
PUEGO
5PM
ID FETCH-LOGICAL-b522t-ff20e569968c12779b1861df94db977edd1f67318c4bc794f8acd8026422efa33
IEDL.DBID BENPR
ISSN 0003-4967
IngestDate Thu Aug 21 18:31:35 EDT 2025
Fri Sep 05 13:47:54 EDT 2025
Wed Aug 13 06:58:27 EDT 2025
Sat Feb 15 01:21:22 EST 2025
Mon Jul 21 09:16:14 EDT 2025
Thu Apr 24 23:00:44 EDT 2025
Tue Jul 01 00:52:55 EDT 2025
Wed Oct 30 09:35:35 EDT 2024
Thu Apr 24 23:01:51 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue suppl 3
Keywords Rheumatism
Treatment
Diseases of the osteoarticular system
Biological agent
Language English
License CC BY 4.0
LinkModel DirectLink
MeetingName Advances in targeted therapies VIII: Proceedings of the Eighth International Symposium, Sorrento, Italy, 5-9 April 2006
MergedId FETCHMERGED-LOGICAL-b522t-ff20e569968c12779b1861df94db977edd1f67318c4bc794f8acd8026422efa33
Notes istex:D73DEFB8C2CE051470311667841EF86CF543318C
ark:/67375/NVC-X55P7VJQ-X
href:annrheumdis-65-iii2.pdf
PMID:17038465
Correspondence to:
 D E Furst
 David Geffen School of Medicine, UCLA – RM 32-59, 1000 Veteran Avenue, Los Angeles, CA 90025, USA; defurst@mednet.ucla.edu
local:0650002
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-News-1
ObjectType-Feature-4
ObjectType-Conference-2
content type line 23
ObjectType-Article-3
Copyright © 2006 BMJ Publishing Group Ltd & European League Against Rheumatism
OpenAccessLink https://ard.bmj.com/content/annrheumdis/65/suppl_3/iii2.full.pdf
PMID 17038465
PQID 1777852006
PQPubID 2041045
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_1798383
proquest_miscellaneous_68959068
proquest_journals_1777852006
pubmed_primary_17038465
pascalfrancis_primary_18248160
crossref_primary_10_1136_ard_2006_061937
crossref_citationtrail_10_1136_ard_2006_061937
istex_primary_ark_67375_NVC_X55P7VJQ_X
bmj_primary_10_1136_ard_2006_061937
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2006-11-01
PublicationDateYYYYMMDD 2006-11-01
PublicationDate_xml – month: 11
  year: 2006
  text: 2006-11-01
  day: 01
PublicationDecade 2000
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
– name: Kidlington
PublicationTitle Annals of the rheumatic diseases
PublicationTitleAlternate Ann Rheum Dis
PublicationYear 2006
Publisher BMJ Publishing Group Ltd and European League Against Rheumatism
BMJ
Elsevier Limited
BMJ Group
Publisher_xml – name: BMJ Publishing Group Ltd and European League Against Rheumatism
– name: BMJ
– name: Elsevier Limited
– name: BMJ Group
References Salvarani (10.1136/ard.2006.061937_bib49) 2003; 49
Tutrone (10.1136/ard.2006.061937_bib57) 2004; 7
Tomero (10.1136/ard.2006.061937_bib88) 2002; 46
Hassard (10.1136/ard.2006.061937_bib93) 2001; 120
Fleischmann (10.1136/ard.2006.061937_bib256) 2005; 52
Korhonen (10.1136/ard.2006.061937_bib143) 2004; 29
Clegg (10.1136/ard.2006.061937_bib50) 1996; 39
Schiff (10.1136/ard.2006.061937_bib72) 2006
Wendling (10.1136/ard.2006.061937_bib105) 2005; 64
10.1136/ard.2006.061937_bib111
Huffstutter (10.1136/ard.2006.061937_bib82) 2002; 46
10.1136/ard.2006.061937_bib239
Willkens (10.1136/ard.2006.061937_bib54) 1984; 27
Cauza (10.1136/ard.2006.061937_bib44) 2002; 22
Spahr (10.1136/ard.2006.061937_bib104) 2002; 37
Hanauer (10.1136/ard.2006.061937_bib215) 2004; 2
Zein (10.1136/ard.2006.061937_bib75) 2005; 42
Keystone (10.1136/ard.2006.061937_bib179) 2005; 74
Cacoub (10.1136/ard.2006.061937_bib123) 2002; 46
Gulli (10.1136/ard.2006.061937_bib92) 2003; 4
McMinn (10.1136/ard.2006.061937_bib124) 2003; 73
Hull (10.1136/ard.2006.061937_bib159) 2002; 81
van Vollenhoven (10.1136/ard.2006.061937_bib257) 2005; 64
Matejicka (10.1136/ard.2006.061937_bib133) 2003; 48
Saadeyh (10.1136/ard.2006.061937_bib116) 2000; 43
Mohan (10.1136/ard.2006.061937_bib181) 2004; 39
Listing (10.1136/ard.2006.061937_bib194) 2005; 54
Weinblatt (10.1136/ard.2006.061937_bib84) 2002; 46
Setoguchi (10.1136/ard.2006.061937_bib199) 2005; 52
Hawkins (10.1136/ard.2006.061937_bib231) 2004; 50
Chaudhari (10.1136/ard.2006.061937_bib60) 2001; 357
Smith (10.1136/ard.2006.061937_bib161) 2005; 53
Geborek (10.1136/ard.2006.061937_bib197) 2005; 64
Breedveld (10.1136/ard.2006.061937_bib13) 2004; 63
Katz (10.1136/ard.2006.061937_bib208) 2004; 99
Hoffman (10.1136/ard.2006.061937_bib157) 2004; 50
Looney (10.1136/ard.2006.061937_bib253) 2005; 44
Lovell (10.1136/ard.2006.061937_bib29) 2003; 48
Kavanaugh (10.1136/ard.2006.061937_bib25) 1998; 24
(10.1136/ard.2006.061937_bib184) 2004; 53
Vesga (10.1136/ard.2006.061937_bib209) 2005; 54
Schiemann (10.1136/ard.2006.061937_bib206) 2002; 40
Wallis (10.1136/ard.2006.061937_bib183) 2004; 39
Lovell (10.1136/ard.2006.061937_bib229) 2005; 52
Abrams (10.1136/ard.2006.061937_bib247) 1999; 103
Lovell (10.1136/ard.2006.061937_bib28) 2000; 342
Lipsky (10.1136/ard.2006.061937_bib27) 2000; 343
Moreland (10.1136/ard.2006.061937_bib245) 2002; 46
Ellman (10.1136/ard.2006.061937_bib151) 2000; 43
Elliott (10.1136/ard.2006.061937_bib18) 1993; 36
Naveau (10.1136/ard.2006.061937_bib103) 2004; 39
Tobinick (10.1136/ard.2006.061937_bib147) 2004; 20
Keystone (10.1136/ard.2006.061937_bib174) 2002; 46
Sfikakis (10.1136/ard.2006.061937_bib99) 2002; 61
Bathon (10.1136/ard.2006.061937_bib12) 2000; 343
Leonardi (10.1136/ard.2006.061937_bib62) 2003; 349
(10.1136/ard.2006.061937_bib80) 2005; 352
Ortiz-Santamaria (10.1136/ard.2006.061937_bib87) 2002; 46
Furst (10.1136/ard.2006.061937_bib1) 2004; 63
Booth (10.1136/ard.2006.061937_bib163) 2004; 15
Tsimberidou (10.1136/ard.2006.061937_bib106) 2004; 51
Fitzgerald (10.1136/ard.2006.061937_bib226) 2005; 52
Kremer (10.1136/ard.2006.061937_bib243) 2003; 349
Gottenberg (10.1136/ard.2006.061937_bib86) 2003; 48
Melikoglu (10.1136/ard.2006.061937_bib76) 2005; 32
Simon (10.1136/ard.2006.061937_bib232) 2004; 117
Edwards (10.1136/ard.2006.061937_bib249) 2004; 350
Utz (10.1136/ard.2006.061937_bib149) 2003; 124
10.1136/ard.2006.061937_bib153
Bingham (10.1136/ard.2006.061937_bib210) 2002; 46
Gorman (10.1136/ard.2006.061937_bib9) 2002; 346
Maini (10.1136/ard.2006.061937_bib36) 1998; 41
10.1136/ard.2006.061937_bib155
van de Putte (10.1136/ard.2006.061937_bib33) 2004; 63
Callejas-Rubio (10.1136/ard.2006.061937_bib142) 2006; 25
Spadaro (10.1136/ard.2006.061937_bib53) 1995; 13
Buch (10.1136/ard.2006.061937_bib171) 2005; 52
Elkayam (10.1136/ard.2006.061937_bib85) 2002; 46
Stone (10.1136/ard.2006.061937_bib200) 2006; 54
Elliott (10.1136/ard.2006.061937_bib19) 1994; 344
Wolff (10.1136/ard.2006.061937_bib122) 2005; 35
Schmeling (10.1136/ard.2006.061937_bib162) 2005; 44
Baert (10.1136/ard.2006.061937_bib74) 2003; 348
Bongartz (10.1136/ard.2006.061937_bib107) 2005; 52
Schiff (10.1136/ard.2006.061937_bib225) 2005; 52
Antoni (10.1136/ard.2006.061937_bib207) 2001; 44
Krueger (10.1136/ard.2006.061937_bib63) 2005; 53
Weinblatt (10.1136/ard.2006.061937_bib195) 2005; 64
Emery (10.1136/ard.2006.061937_bib250) 2005; 52
10.1136/ard.2006.061937_bib165
Ogilvie (10.1136/ard.2006.061937_bib48) 2001; 144
Pritchard (10.1136/ard.2006.061937_bib126) 1999; 5
Burns (10.1136/ard.2006.061937_bib131) 2005; 146
Baeten (10.1136/ard.2006.061937_bib68) 2003; 62
Vasques Godinho (10.1136/ard.2006.061937_bib227) 2005; 64
Cortis (10.1136/ard.2006.061937_bib108) 2004; 145
St Clair (10.1136/ard.2006.061937_bib38) 2004; 50
Birnbaum (10.1136/ard.2006.061937_bib134) 2000; 133
Steinfeld (10.1136/ard.2006.061937_bib77) 2001; 44
Kremer (10.1136/ard.2006.061937_bib246) 2006; 144
Genovese (10.1136/ard.2006.061937_bib37) 2002; 46
Braun (10.1136/ard.2006.061937_bib69) 2005; 64
10.1136/ard.2006.061937_bib91
Weiss (10.1136/ard.2006.061937_bib130) 2004; 31
Feinstein (10.1136/ard.2006.061937_bib164) 2005; 11
Robinson (10.1136/ard.2006.061937_bib89) 2003; 139
Hyrich (10.1136/ard.2006.061937_bib178) 2004; 63
Verbsky (10.1136/ard.2006.061937_bib228) 2004; 31
Davis (10.1136/ard.2006.061937_bib166) 2004; 51
Esteve (10.1136/ard.2006.061937_bib205) 2004; 53
Garrison (10.1136/ard.2006.061937_bib186) 1999; 58
van Vollenhoven (10.1136/ard.2006.061937_bib258) 2005; 52
Mease (10.1136/ard.2006.061937_bib43) 2003; 8
Tan (10.1136/ard.2006.061937_bib121) 2003; 62
Oniankitan (10.1136/ard.2006.061937_bib204) 2004; 31
Van Den Bosch (10.1136/ard.2006.061937_bib10) 2002; 46
Patel (10.1136/ard.2006.061937_bib64) 2004; 17
Jarvis (10.1136/ard.2006.061937_bib23) 1999; 57
Moreland (10.1136/ard.2006.061937_bib32) 1999; 130
Prior (10.1136/ard.2006.061937_bib198) 1984; 43
Cohen (10.1136/ard.2006.061937_bib248) 2005; 52
Athreya (10.1136/ard.2006.061937_bib135) 2000; 43
Bosello (10.1136/ard.2006.061937_bib152) 2005; 143
Furst (10.1136/ard.2006.061937_bib20) 1999; 38
Shaw (10.1136/ard.2006.061937_bib254) 2003; 62
Takada (10.1136/ard.2006.061937_bib117) 2003; 48
Andonopoulos (10.1136/ard.2006.061937_bib119) 2003; 62
Licata (10.1136/ard.2006.061937_bib94) 2003; 62
Miller (10.1136/ard.2006.061937_bib113) 2002; 46
Rycke (10.1136/ard.2006.061937_bib216) 2005; 14
Doran (10.1136/ard.2006.061937_bib191) 2002; 46
Chevalier (10.1136/ard.2006.061937_bib235) 2005; 32
Sweiss (10.1136/ard.2006.061937_bib141) 2005; 53
Carter (10.1136/ard.2006.061937_bib138) 2005; 32
Slifman (10.1136/ard.2006.061937_bib193) 2003; 48
Dougados (10.1136/ard.2006.061937_bib51) 1995; 38
10.1136/ard.2006.061937_bib71
Lee (10.1136/ard.2006.061937_bib188) 2002; 46
Fleischmann (10.1136/ard.2006.061937_bib223) 2004; 1
10.1136/ard.2006.061937_bib70
Emery (10.1136/ard.2006.061937_bib251) 2004; 50
Fleischmann (10.1136/ard.2006.061937_bib40) 2004; 3
Maksymowych (10.1136/ard.2006.061937_bib169) 2001; 44
Tan (10.1136/ard.2006.061937_bib234) 2004; 63
Mease (10.1136/ard.2006.061937_bib46) 2000; 356
Cohen (10.1136/ard.2006.061937_bib81) 2005; 26
Ribi (10.1136/ard.2006.061937_bib100) 2005; 76
Quinn (10.1136/ard.2006.061937_bib175) 2005; 52
Allanore (10.1136/ard.2006.061937_bib214) 2004; 22
Ozgocmen (10.1136/ard.2006.061937_bib118) 2006; 25
Shekelle (10.1136/ard.2006.061937_bib2) 1999; 318
Gladman (10.1136/ard.2006.061937_bib5) 2004; 50
Whiting-O'Keefe (10.1136/ard.2006.061937_bib219) 1991; 90
Braun (10.1136/ard.2006.061937_bib65) 2003; 62
Magliocco (10.1136/ard.2006.061937_bib128) 2004; 51
Principi (10.1136/ard.2006.061937_bib156) 2004; 26
Emery (10.1136/ard.2006.061937_bib255) 2003; 48
Goupille (10.1136/ard.2006.061937_bib52) 1996; 23
Scheinfeld (10.1136/ard.2006.061937_bib41) 2003; 2
Peterson (10.1136/ard.2006.061937_bib125) 2003; 62
Mohan (10.1136/ard.2006.061937_bib218) 2001; 44
Rozenbaum (10.1136/ard.2006.061937_bib96) 2002; 61
Curran (10.1136/ard.2006.061937_bib17) 2004; 172
Saulsbury (10.1136/ard.2006.061937_bib97) 2003; 49
Culy (10.1136/ard.2006.061937_bib15) 2002; 62
Kraetsch (10.1136/ard.2006.061937_bib83) 2001; 60
Klareskog (10.1136/ard.2006.061937_bib26) 2004; 363
Haibel (10.1136/ard.2006.061937_bib172) 2006; 54
Khanna (10.1136/ard.2006.061937_bib202) 2004; 50
Haibel (10.1136/ard.2006.061937_bib233) 2005; 64
Kremer (10.1136/ard.2006.061937_bib244) 2005; 52
Carrasco (10.1136/ard.2006.061937_bib237) 2004; 6
Braun (10.1136/ard.2006.061937_bib7) 2002; 359
Opal (10.1136/ard.2006.061937_bib240) 1997; 25
Lovelace (10.1136/ard.2006.061937_bib132) 2005; 141
Mease (10.1136/ard.2006.061937_bib176) 2005; 64
Smolen (10.1136/ard.2006.061937_bib34) 2005; 52
Melikoghu (10.1136/ard.2006.061937_bib95) 2002; 46
Bang (10.1136/ard.2006.061937_bib11) 2004; 18
Mease (10.1136/ard.2006.061937_bib55) 2005; 52
Cantini (10.1136/ard.2006.061937_bib120) 2001; 44
Fleischmann (10.1136/ard.2006.061937_bib224) 2006; 65
Hanauer (10.1136/ard.2006.061937_bib73) 2002; 359
Smith (10.1136/ard.2006.061937_bib129) 2001; 144
10.1136/ard.2006.061937_bib61
Davis (10.1136/ard.2006.061937_bib8) 2003; 48
Filler (10.1136/ard.2006.061937_bib190) 2005; 41
Antin (10.1136/ard.2006.061937_bib241) 2002; 100
Ince (10.1136/ard.2006.061937_bib127) 2002; 61
Keane (10.1136/ard.2006.061937_bib185) 2001; 345
Khanna (10.1136/ard.2006.061937_bib148) 2003; 30
Bargstrom (10.1136/ard.2006.061937_bib187) 2004; 46
Ehresman (10.1136/ard.2006.061937_bib139) 2002; 46
Markham (10.1136/ard.2006.061937_bib30) 2000; 59
Pascual (10.1136/ard.2006.061937_bib238) 2005; 201
Ruderman (10.1136/ard.2006.061937_bib217) 2003; 48
Alexander (10.1136/ard.2006.061937_bib230) 2005; 64
Mariette (10.1136/ard.2006.061937_bib78) 2004; 50
Lam (10.1136/ard.2006.061937_bib145) 2005; 52
Pasternack (10.1136/ard.2006.061937_bib146) 2005; 141
Cush (10.1136/ard.2006.061937_bib201) 2002
Korhonen (10.1136/ard.2006.061937_bib144) 2005; 30
10.1136/ard.2006.061937_bib58
Anker (10.1136/ard.2006.061937_bib140) 2002; 86
10.1136/ard.2006.061937_bib56
Hengstman (10.1136/ard.2006.061937_bib112) 2000; 43
Joseph (10.1136/ard.2006.061937_bib160) 2003; 110
Jones (10.1136/ard.2006.061937_bib24) 1999; 48
Sankar (10.1136/ard.2006.061937_bib79) 2004; 50
Antoni (10.1136/ard.2006.061937_bib42) 2002;
References_xml – volume: 50
  start-page: 1040
  year: 2004
  ident: 10.1136/ard.2006.061937_bib202
  article-title: Anti-tumor necrosis factor alpha therapy and heart failure: what have we learned and where do we go from here?
  publication-title: Arthritis Rheum
  doi: 10.1002/art.20164
– ident: 10.1136/ard.2006.061937_bib58
– volume: 25
  start-page: 83
  year: 2006
  ident: 10.1136/ard.2006.061937_bib118
  article-title: Familial Mediterranean fever responds well to infliximab: single case experience.
  publication-title: Clin Rheumatol
  doi: 10.1007/s10067-005-1122-9
– volume: 48
  start-page: 1667
  year: 2003
  ident: 10.1136/ard.2006.061937_bib6
  article-title: Six-month results of a double-blind, placebo-controlled trial of etanercept treatment in patients with active ankylosing spondylitis.
  publication-title: Arthritis Rheum
  doi: 10.1002/art.11017
– volume: 46
  start-page: S326
  issue: suppl
  year: 2002
  ident: 10.1136/ard.2006.061937_bib82
  article-title: Resistant adult still's disease treated with infliximab—a report of two cases [abstract].
  publication-title: Arthritis Rheum
– year: 2002
  ident: 10.1136/ard.2006.061937_bib201
  article-title: Etanercept update on “dear doctor” safety letter [electronic citation].
  publication-title: ACR Hotline
– volume: 52
  start-page: 2263
  year: 2005
  ident: 10.1136/ard.2006.061937_bib244
  article-title: Treatment of rheumatoid arthritis with the selective costimulation modulator abatacept: twelve-month results of a phase iib, double-blind, randomized, placebo-controlled trial.
  publication-title: Arthritis Rheum
  doi: 10.1002/art.21201
– volume: 103
  start-page: 1243
  year: 1999
  ident: 10.1136/ard.2006.061937_bib247
  article-title: CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris.
  publication-title: J Clin Invest
  doi: 10.1172/JCI5857
– volume: 346
  start-page: 1349
  year: 2002
  ident: 10.1136/ard.2006.061937_bib9
  article-title: Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha.
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa012664
– volume: 30
  start-page: 2724
  year: 2005
  ident: 10.1136/ard.2006.061937_bib144
  article-title: The treatment of disc herniation-induced sciatica with infliximab: results of a randomized, controlled, 3-month follow-up study.
  publication-title: Spine
  doi: 10.1097/01.brs.0000190815.13764.64
– volume: 54
  start-page: 890
  year: 2005
  ident: 10.1136/ard.2006.061937_bib209
  article-title: Adalimumab use in pregnancy.
  publication-title: Gut
  doi: 10.1136/gut.2005.065417
– volume: 31
  start-page: 1103
  year: 2004
  ident: 10.1136/ard.2006.061937_bib222
  article-title: Effects of anakinra monotherapy on joint damage in patients with rheumatoid arthritis. Extension of a 24-week randomized, placebo-controlled trial
  publication-title: J Rheumatol
– volume: 46
  start-page: S70
  issue: suppl
  year: 2002
  ident: 10.1136/ard.2006.061937_bib88
  article-title: Infliximab in secondary amyloidosis complicating inflammatory arthropathies [abstract].
  publication-title: Arthritis Rheum
– volume: 15
  start-page: 717
  year: 2004
  ident: 10.1136/ard.2006.061937_bib163
  article-title: Prospective study of TNFalpha blockade with infliximab in anti-neutrophil cytoplasmic antibody-associated systemic vasculitis.
  publication-title: J Am Soc Nephrol
  doi: 10.1097/01.ASN.0000114554.67106.28
– volume: 62
  start-page: ii13
  issue: suppl 2
  year: 2003
  ident: 10.1136/ard.2006.061937_bib168
  article-title: Comparison of the efficacy of the tumour necrosis factor alpha blocking agents adalimumab, etanercept, and infliximab when added to methotrexate in patients with active rheumatoid arthritis
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.62.suppl_2.ii13
– volume: 30
  start-page: 17
  year: 2001
  ident: 10.1136/ard.2006.061937_bib220
  article-title: The safety and efficacy of interleukin-1 receptor antagonist in the treatment of rheumatoid arthritis.
  publication-title: Semin Arthritis Rheum
  doi: 10.1053/sarh.2001.23701
– volume: 61
  start-page: ii51
  issue: suppl 2
  year: 2002
  ident: 10.1136/ard.2006.061937_bib99
  article-title: Behcet's disease: a new target for anti-tumour necrosis factor treatment.
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.61.suppl_2.ii51
– volume: 43
  start-page: S392
  issue: suppl
  year: 2000
  ident: 10.1136/ard.2006.061937_bib151
  article-title: Etanercept treatment for diffuse scleroderma: a pilot study [abstract].
  publication-title: Arthritis Rheum
– ident: 10.1136/ard.2006.061937_bib153
– volume: 17
  start-page: 427
  year: 2004
  ident: 10.1136/ard.2006.061937_bib64
  article-title: Adalimumab: efficacy and safety in psoriasis and rheumatoid arthritis.
  publication-title: Dermatol Ther
  doi: 10.1111/j.1396-0296.2004.04045.x
– volume: 139
  start-page: 1259
  year: 2003
  ident: 10.1136/ard.2006.061937_bib89
  article-title: Recalcitrant, recurrent aphthous stomatitis treated with etanercept
  publication-title: Arch Dermatol
  doi: 10.1001/archderm.139.10.1259
– volume: 46
  start-page: 3317
  year: 2002
  ident: 10.1136/ard.2006.061937_bib123
  article-title: Interferon-alpha and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis.
  publication-title: Arthritis Rheum
  doi: 10.1002/art.10699
– volume: 44
  start-page: 406
  year: 2005
  ident: 10.1136/ard.2006.061937_bib236
  article-title: Anakinra for flares of pyogenic arthritis in PAPA syndrome.
  publication-title: Rheumatology (Oxford)
  doi: 10.1093/rheumatology/keh479
– ident: 10.1136/ard.2006.061937_bib101
– volume: 46
  start-page: 2571
  year: 2002
  ident: 10.1136/ard.2006.061937_bib85
  article-title: Rapid and complete resolution of proteinuria due to renal amyloidosis in a patient with rheumatoid arthritis treated with infliximab.
  publication-title: Arthritis Rheum
  doi: 10.1002/art.10581
– volume: 29
  start-page: 2115
  year: 2004
  ident: 10.1136/ard.2006.061937_bib143
  article-title: Efficacy of infliximab for disc herniation-induced sciatica: one-year follow-up.
  publication-title: Spine
  doi: 10.1097/01.brs.0000141179.58778.6c
– volume: 44
  start-page: 2862
  year: 2001
  ident: 10.1136/ard.2006.061937_bib218
  article-title: Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritides.
  publication-title: Arthritis Rheum
  doi: 10.1002/1529-0131(200112)44:12<2862::AID-ART474>3.0.CO;2-W
– volume: 124
  start-page: 177
  year: 2003
  ident: 10.1136/ard.2006.061937_bib149
  article-title: Etanercept for the treatment of stage II and III progressive pulmonary sarcoidosis.
  publication-title: Chest
  doi: 10.1378/chest.124.1.177
– volume: 38
  start-page: 50
  issue: suppl 2
  year: 1999
  ident: 10.1136/ard.2006.061937_bib20
  article-title: Recapitulation of the round-table discussion—assessing the role of anti-tumour necrosis factor therapy in the treatment of rheumatoid arthritis.
  publication-title: Rheumatology (Oxford)
– volume: 26
  start-page: 903
  year: 2005
  ident: 10.1136/ard.2006.061937_bib81
  article-title: Etanercept treatment for autoimmune inner ear disease: results of a pilot placebo-controlled study.
  publication-title: Otol Neurotol
  doi: 10.1097/01.mao.0000185082.28598.87
– volume: 53
  start-page: 1363
  year: 2004
  ident: 10.1136/ard.2006.061937_bib205
  article-title: Chronic hepatitis B reactivation following infliximab therapy in Crohn's disease patients: need for primary prophylaxis.
  publication-title: Gut
  doi: 10.1136/gut.2004.040675
– volume: 52
  start-page: 1830
  year: 2005
  ident: 10.1136/ard.2006.061937_bib248
  article-title: Efficacy and safety of rituximab in active RA patients who experienced an inadequate response to one or more anti-TNF-alpha therapies.
  publication-title: Arthritis Rheum
– volume: 52
  start-page: s737
  issue: suppl.
  year: 2005
  ident: 10.1136/ard.2006.061937_bib59
  article-title: Patients related with TNF-or antagonists increase their participation in the workforce [abstract].
  publication-title: Arthritis Rheum
– volume: 64
  start-page: 296
  year: 2005
  ident: 10.1136/ard.2006.061937_bib233
  article-title: Open label trial of anakinra in active ankylosing spondylitis over 24 weeks.
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.2004.023176
– volume: 62
  start-page: ii55
  issue: suppl 2
  year: 2003
  ident: 10.1136/ard.2006.061937_bib254
  article-title: B cell therapy for rheumatoid arthritis: the rituximab (anti-CD20) experience.
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.62.suppl_2.ii55
– volume: 59
  start-page: 1341
  year: 2000
  ident: 10.1136/ard.2006.061937_bib30
  article-title: Infliximab: a review of its use in the management of rheumatoid arthritis.
  publication-title: Drugs
  doi: 10.2165/00003495-200059060-00010
– volume: 64
  start-page: 229
  year: 2005
  ident: 10.1136/ard.2006.061937_bib69
  article-title: Two year maintenance of efficacy and safety of infliximab in the treatment of ankylosing spondylitis.
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.2004.025130
– volume: 46
  start-page: 1171
  year: 2002
  ident: 10.1136/ard.2006.061937_bib84
  article-title: Etanercept in the treatment of adult patients with Still's disease.
  publication-title: Arthritis Rheum
  doi: 10.1002/art.10231
– volume: 50
  start-page: 1400
  year: 2004
  ident: 10.1136/ard.2006.061937_bib39
  publication-title: Arthritis Rheum
  doi: 10.1002/art.20217
– volume: 7
  start-page: 45
  year: 2004
  ident: 10.1136/ard.2006.061937_bib57
  article-title: Biological therapy for psoriasis: an overview of infliximab, etanercept, efalizumab and alefacept
  publication-title: IDrugs
– volume: 62
  start-page: 280
  year: 2003
  ident: 10.1136/ard.2006.061937_bib94
  article-title: Anti-tumour necrosis factor alpha monoclonal antibody therapy for recalcitrant cerebral vasculitis in a patient with Behcet's syndrome.
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.62.3.280
– volume: 48
  start-page: 3230
  year: 2003
  ident: 10.1136/ard.2006.061937_bib8
  article-title: Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: a randomized, controlled trial.
  publication-title: Arthritis Rheum
  doi: 10.1002/art.11325
– volume: 43
  start-page: S193
  issue: suppl
  year: 2000
  ident: 10.1136/ard.2006.061937_bib116
  article-title: Etanercept is effective in the treatment of Polymyositis/dermatomyositis which is refractory to conventional therapy [abstract].
  publication-title: Arthritis Rheum
– volume: 61
  start-page: 191
  issue: suppl 1
  year: 2002
  ident: 10.1136/ard.2006.061937_bib127
  article-title: Etanercept in the treatment of rheumatoid arthritis patients with chronic hepatitis C infection [abstract].
  publication-title: Ann Rheum Dis
– ident: 10.1136/ard.2006.061937_bib71
– volume: 50
  start-page: 24
  year: 2004
  ident: 10.1136/ard.2006.061937_bib5
  article-title: Assessment of patients with psoriatic arthritis: a review of currently available measures.
  publication-title: Arthritis Rheum
  doi: 10.1002/art.11417
– volume: 50
  start-page: 2264
  year: 2004
  ident: 10.1136/ard.2006.061937_bib47
  article-title: Etanercept treatment of psoriatic arthritis: safety, efficacy, and effect on disease progression.
  publication-title: Arthritis Rheum
  doi: 10.1002/art.20335
– volume: 99
  start-page: 511
  year: 2005
  ident: 10.1136/ard.2006.061937_bib102
  article-title: Improvement of refractory rheumatoid arthritis-associated constrictive bronchiolitis with etanercept.
  publication-title: Respir Med
  doi: 10.1016/j.rmed.2004.09.001
– ident: 10.1136/ard.2006.061937_bib165
– volume: 74
  start-page: 8
  year: 2005
  ident: 10.1136/ard.2006.061937_bib179
  article-title: Safety of biologic therapies—an update.
  publication-title: J Rheumatol Suppl
  doi: 10.1093/rheumatology/keh617
– volume: 3
  start-page: 391
  year: 2004
  ident: 10.1136/ard.2006.061937_bib40
  article-title: Considerations with the use of biological therapy in the treatment of rheumatoid arthritis.
  publication-title: Expert Opin Drug Saf
  doi: 10.1517/14740338.3.5.391
– volume: 64
  start-page: 1245
  year: 2005
  ident: 10.1136/ard.2006.061937_bib230
  article-title: Successful treatment of acute visual loss in Muckle-Wells syndrome with interleukin 1 receptor antagonist.
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.2004.032060
– volume: 18
  start-page: 121
  year: 2004
  ident: 10.1136/ard.2006.061937_bib11
  article-title: Adalimumab: a review of its use in rheumatoid arthritis.
  publication-title: BioDrugs
  doi: 10.2165/00063030-200418020-00005
– volume: 144
  start-page: 865
  year: 2006
  ident: 10.1136/ard.2006.061937_bib246
  article-title: Effects of abatacept in patients with methotrexate-resistant, active RA: a randomized trial.
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-144-12-200606200-00003
– volume: 11
  start-page: 219
  year: 2005
  ident: 10.1136/ard.2006.061937_bib164
  article-title: Successful treatment of childhood onset refractory polyarteritis nodosa with tumor necrosis factor alpha blockade.
  publication-title: J Clin Rheumatol
  doi: 10.1097/01.rhu.0000173225.41933.83
– year: 2006
  ident: 10.1136/ard.2006.061937_bib72
  article-title: Safety analyses of adalimumab (Humira) in global clinical trials and US postmarketing surveillance of patients with rheumatoid arthritis.
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.2005.043166
– volume: 14
  start-page: 931
  year: 2005
  ident: 10.1136/ard.2006.061937_bib216
  article-title: The effect of TNFalpha blockade on the antinuclear antibody profile in patients with chronic arthritis: biological and clinical implications.
  publication-title: Lupus
  doi: 10.1191/0961203305lu2240rr
– volume: 35
  start-page: 1003
  year: 2005
  ident: 10.1136/ard.2006.061937_bib122
  article-title: Treatment of steroid-resistant acute graft-versus-host disease with daclizumab and etanercept.
  publication-title: Bone Marrow Transplant
  doi: 10.1038/sj.bmt.1704929
– volume: 44
  start-page: S82
  issue: suppl
  year: 2001
  ident: 10.1136/ard.2006.061937_bib169
  article-title: Alberta Capital Health region studies in rheumatoid arthritis prospective observational inception cohort: efficacy, adverse events and withdrawal [abstract]
  publication-title: Arthritis Rheum
– volume: 352
  start-page: 351
  year: 2005
  ident: 10.1136/ard.2006.061937_bib80
  article-title: Etanercept plus standard therapy for Wegener's granulomatosis.
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa041884
– volume: 50
  start-page: S659
  issue: suppl 9
  year: 2004
  ident: 10.1136/ard.2006.061937_bib251
  article-title: Efficacy and safety of rituximab at 2 years following a single treatment in patients with active rheumatoid arthritis [abstract].
  publication-title: Arthritis Rheum
– volume: 54
  start-page: 26
  year: 2006
  ident: 10.1136/ard.2006.061937_bib35
  publication-title: Arthritis Rheum
  doi: 10.1002/art.21519
– volume: 63
  start-page: 1538
  year: 2004
  ident: 10.1136/ard.2006.061937_bib178
  article-title: Anti-tumour necrosis factor alpha therapy in rheumatoid arthritis: an update on safety.
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.2004.024737
– volume: 2
  start-page: 375
  year: 2003
  ident: 10.1136/ard.2006.061937_bib41
  article-title: Adalimumab (HUMIRA): a review.
  publication-title: J Drugs Dermatol
– volume: 23
  start-page: 791
  year: 1996
  ident: 10.1136/ard.2006.061937_bib52
  article-title: Sulfasalazine: a definitively efficient treatment for psoriatic arthritis.
  publication-title: J Rheumatol
– volume: 64
  start-page: 788
  year: 2005
  ident: 10.1136/ard.2006.061937_bib105
  article-title: Reactivation of a latent precore mutant hepatitis B virus related chronic hepatitis during infliximab treatment for severe spondyloarthropathy.
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.2004.031187
– volume: 49
  start-page: 541
  year: 2003
  ident: 10.1136/ard.2006.061937_bib49
  article-title: Efficacy of infliximab in resistant psoriatic arthritis.
  publication-title: Arthritis Rheum
  doi: 10.1002/art.11201
– volume: 342
  start-page: 763
  year: 2000
  ident: 10.1136/ard.2006.061937_bib28
  article-title: Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group.
  publication-title: N Engl J Med
  doi: 10.1056/NEJM200003163421103
– volume: 349
  start-page: 1907
  year: 2003
  ident: 10.1136/ard.2006.061937_bib243
  article-title: Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig.
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa035075
– volume: 6
  start-page: 137
  year: 2004
  ident: 10.1136/ard.2006.061937_bib237
  article-title: Biologic agents for the treatment of juvenile rheumatoid arthritis: current status.
  publication-title: Paediatr Drugs
  doi: 10.2165/00148581-200406030-00001
– volume: 356
  start-page: 385
  year: 2000
  ident: 10.1136/ard.2006.061937_bib46
  article-title: Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial.
  publication-title: Lancet
  doi: 10.1016/S0140-6736(00)02530-7
– volume: 154
  start-page: 726
  year: 2006
  ident: 10.1136/ard.2006.061937_bib110
  article-title: Etanercept effective in the management of hidradenitis suppurativa.
  publication-title: Br J Dermatol
  doi: 10.1111/j.1365-2133.2005.07067.x
– volume: 53
  start-page: 788
  year: 2005
  ident: 10.1136/ard.2006.061937_bib141
  article-title: TNF-inhibitor as novel treatment for refractory sarcoidosis.
  publication-title: Arthritis Rheum
  doi: 10.1002/art.21468
– volume: 50
  start-page: 607
  year: 2004
  ident: 10.1136/ard.2006.061937_bib231
  article-title: Spectrum of clinical features in Muckle-Wells syndrome and response to anakinra.
  publication-title: Arthritis Rheum
  doi: 10.1002/art.20033
– volume: 46
  start-page: s537
  year: 2002
  ident: 10.1136/ard.2006.061937_bib167
  article-title: Long term efficacy and safety of adalimumab monotherapy in patients with DMARD-refractory RA-results from a two year study [abstract].
  publication-title: Arthritis Rheum
– volume: 43
  start-page: 524
  year: 2004
  ident: 10.1136/ard.2006.061937_bib114
  article-title: Treatment of myositis with etanercept (Enbrel), a recombinant human soluble fusion protein of TNF-alpha type II receptor and IgG1
  publication-title: Rheumatology (Oxford)
  doi: 10.1093/rheumatology/keh062
– volume: 32
  start-page: 1413
  year: 2005
  ident: 10.1136/ard.2006.061937_bib138
  article-title: Treatment of relapsing polychondritis with a TNF antagonist.
  publication-title: J Rheumatol
– volume: 64
  start-page: 497
  year: 2005
  ident: 10.1136/ard.2006.061937_bib136
  article-title: Tumour necrosis factor alpha blockade in treatment resistant pigmented villonodular synovitis.
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.2004.025692
– volume: 48
  start-page: 2019
  year: 2003
  ident: 10.1136/ard.2006.061937_bib86
  article-title: Anti-tumor necrosis factor alpha therapy in fifteen patients with AA amyloidosis secondary to inflammatory arthritides: a followup report of tolerability and efficacy.
  publication-title: Arthritis Rheum
  doi: 10.1002/art.11163
– volume: 62
  start-page: 1078
  year: 2003
  ident: 10.1136/ard.2006.061937_bib125
  article-title: Effect of tumour necrosis factor alpha antagonists on serum transaminases and viraemia in patients with rheumatoid arthritis and chronic hepatitis C infection.
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.62.11.1078
– volume: 62
  start-page: 2493
  year: 2002
  ident: 10.1136/ard.2006.061937_bib15
  article-title: Etanercept: an updated review of its use in rheumatoid arthritis, psoriatic arthritis and juvenile rheumatoid arthritis
  publication-title: Drugs
  doi: 10.2165/00003495-200262170-00013
– volume: 141
  start-page: 13
  year: 2005
  ident: 10.1136/ard.2006.061937_bib146
  article-title: Silicone granulomas treated with etanercept.
  publication-title: Arch Dermatol
  doi: 10.1001/archderm.141.1.13
– volume: 43
  start-page: S117
  issue: suppl
  year: 2000
  ident: 10.1136/ard.2006.061937_bib135
  article-title: Periodic fever syndrome in children [abstract].
  publication-title: Arthritis Rheum
– volume: 73
  start-page: 135
  year: 2003
  ident: 10.1136/ard.2006.061937_bib124
  article-title: Complete recovery from refractory immune thrombocytopenic purpura in three patients treated with etanercept.
  publication-title: Am J Hematol
  doi: 10.1002/ajh.10331
– volume: 52
  start-page: 287
  year: 2005
  ident: 10.1136/ard.2006.061937_bib252
  article-title: Improved quality of life with rituximab plus methotrexate in patients with active rheumatoid arthritis who experienced inadequate response to one or more anti-TNF-alpha therapies.
  publication-title: Arthritis Rheum
– ident: 10.1136/ard.2006.061937_bib111
– volume: 359
  start-page: 1541
  year: 2002
  ident: 10.1136/ard.2006.061937_bib73
  article-title: Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial.
  publication-title: Lancet
  doi: 10.1016/S0140-6736(02)08512-4
– volume: 52
  start-page: 1917
  year: 2005
  ident: 10.1136/ard.2006.061937_bib250
  article-title: Rituximab in rheumatoid arthritis: a double-blind, placebo-controlled, dose-ranging trial.
  publication-title: Arthritis Rheum
– volume: 5
  start-page: 179
  year: 1999
  ident: 10.1136/ard.2006.061937_bib126
  article-title: Etanercept and hepatitis C.
  publication-title: J Clin Rheumtol
  doi: 10.1097/00124743-199906000-00015
– volume: 23
  start-page: 795
  year: 2005
  ident: 10.1136/ard.2006.061937_bib170
  article-title: The efficiency of switching from infliximab to etanercept and vice-versa in patients with rheumatoid arthritis.
  publication-title: Clin Exp Rheumatol
– volume: 343
  start-page: 1586
  year: 2000
  ident: 10.1136/ard.2006.061937_bib12
  article-title: A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis.
  publication-title: N Engl J Med
  doi: 10.1056/NEJM200011303432201
– volume: 44
  start-page: ii13
  issue: suppl 2
  year: 2005
  ident: 10.1136/ard.2006.061937_bib253
  article-title: B cells as a therapeutic target in autoimmune diseases other than rheumatoid arthritis.
  publication-title: Rheumatology (Oxford)
  doi: 10.1093/rheumatology/keh618
– volume: 28
  start-page: 1712
  year: 2001
  ident: 10.1136/ard.2006.061937_bib3
  article-title: Evaluation and documentation of rheumatoid arthritis disease status in the clinic: which variables best predict change in therapy.
  publication-title: J Rheumatol
– volume: 31
  start-page: 2071
  year: 2004
  ident: 10.1136/ard.2006.061937_bib228
  article-title: Effective use of the recombinant interleukin 1 receptor antagonist anakinra in therapy resistant systemic onset juvenile rheumatoid arthritis.
  publication-title: J Rheumatol
– volume: 343
  start-page: 1594
  year: 2000
  ident: 10.1136/ard.2006.061937_bib27
  article-title: Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group.
  publication-title: N Engl J Med
  doi: 10.1056/NEJM200011303432202
– volume: 39
  start-page: 2013
  year: 1996
  ident: 10.1136/ard.2006.061937_bib50
  article-title: Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis. A Department of Veterans Affairs Cooperative Study.
  publication-title: Arthritis Rheum
  doi: 10.1002/art.1780391210
– volume: 43
  start-page: S193
  issue: suppl
  year: 2000
  ident: 10.1136/ard.2006.061937_bib112
  article-title: Anti-TNF blockade with infliximab (Remicade) in polymyositis and dermatomyositis [abstract].
  publication-title: Arthritis Rheum
– volume: 52
  start-page: S588
  year: 2005
  ident: 10.1136/ard.2006.061937_bib145
  article-title: Efficacy and safety of etanercept in scleroderma joint disease [abstract].
  publication-title: Arthritis Rheum
– volume: 24
  start-page: 304
  year: 2005
  ident: 10.1136/ard.2006.061937_bib158
  article-title: Refractory Takayasu's arteritis successfully treated with the human, monoclonal anti-tumor necrosis factor antibody adalimumab
  publication-title: Int Angiol
– volume: 44
  start-page: 1008
  year: 2005
  ident: 10.1136/ard.2006.061937_bib162
  article-title: Etanercept and uveitis in patients with juvenile idiopathic arthritis.
  publication-title: Rheumatology (Oxford)
  doi: 10.1093/rheumatology/keh658
– volume: 51
  start-page: 302
  year: 2004
  ident: 10.1136/ard.2006.061937_bib166
  article-title: Results from an open-label extension study of etanercept in ankylosing spondylitis.
  publication-title: Arthritis Rheum
  doi: 10.1002/art.20241
– volume: 30
  start-page: 2563
  year: 2003
  ident: 10.1136/ard.2006.061937_bib21
  article-title: Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis).
  publication-title: J Rheumatol
– volume: 46
  start-page: S429
  year: 2004
  ident: 10.1136/ard.2006.061937_bib67
  article-title: Six months results of a German double-blind placebo controlled Phase III clinical trial in active ankylosing spondylitis.
  publication-title: Arthritis Rheum
– volume: 36
  start-page: 1681
  year: 1993
  ident: 10.1136/ard.2006.061937_bib18
  article-title: Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha.
  publication-title: Arthritis Rheum
  doi: 10.1002/art.1780361206
– volume: 52
  start-page: 263
  year: 2005
  ident: 10.1136/ard.2006.061937_bib256
  article-title: Rituximab efficacy in rheumatoid arthritis is independent of coadministration of glucocorticoids: Results from the Dose-ranging Assessment iNternational Clinical Evaluation of Rituximab in rheumatoid arthritis (DANCER) Study [abstract].
  publication-title: Arthritis Rheum
– volume: 363
  start-page: 675
  year: 2004
  ident: 10.1136/ard.2006.061937_bib26
  article-title: Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial.
  publication-title: Lancet
  doi: 10.1016/S0140-6736(04)15640-7
– volume: 52
  start-page: 1020
  year: 2005
  ident: 10.1136/ard.2006.061937_bib34
  publication-title: Arthritis Rheum
  doi: 10.1002/art.20982
– ident: 10.1136/ard.2006.061937_bib56
– volume: 14
  start-page: 229
  year: 2003
  ident: 10.1136/ard.2006.061937_bib203
  article-title: Etanercept therapy in patients with autoimmunity and hepatitis C.
  publication-title: J Dermatolog Treat
  doi: 10.1080/09546630310020470
– volume: 63
  start-page: ii2
  issue: suppl 2
  year: 2004
  ident: 10.1136/ard.2006.061937_bib1
  article-title: Updated consensus statement on biological agents, specifically tumour necrosis factor alpha (TNFalpha) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2004.
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.2004.029272
– volume: 32
  start-page: 1317
  year: 2005
  ident: 10.1136/ard.2006.061937_bib235
  article-title: Safety study of intraarticular injection of interleukin 1 receptor antagonist in patients with painful knee osteoarthritis: a multicenter study.
  publication-title: J Rheumatol
– ident: 10.1136/ard.2006.061937_bib155
– year: 2006
  ident: 10.1136/ard.2006.061937_bib177
  article-title: Tumor necrosis factor antagonists and granulomatous infections: mechanisms of action.
  publication-title: J Rheumatol
– volume: 31
  start-page: 808
  year: 2004
  ident: 10.1136/ard.2006.061937_bib130
  article-title: Infliximab as a novel therapy for refractory Kawasaki disease.
  publication-title: J Rheumatol
– volume: 48
  start-page: 927
  year: 2003
  ident: 10.1136/ard.2006.061937_bib221
  article-title: Anakinra, a recombinant human interleukin-1 receptor antagonist (r-metHuIL-1ra), in patients with rheumatoid arthritis: A large, international, multicenter, placebo-controlled trial.
  publication-title: Arthritis Rheum
  doi: 10.1002/art.10870
– volume: 54
  start-page: 1608
  year: 2006
  ident: 10.1136/ard.2006.061937_bib200
  article-title: Solid malignancies among patients in the Wegener's Granulomatosis Etanercept Trial.
  publication-title: Arthritis Rheum
  doi: 10.1002/art.21869
– volume: 48
  start-page: 1015
  year: 2003
  ident: 10.1136/ard.2006.061937_bib212
  article-title: Antinuclear antibodies following infliximab treatment in patients with rheumatoid arthritis or spondylarthropathy.
  publication-title: Arthritis Rheum
  doi: 10.1002/art.10876
– volume: 58
  start-page: I65
  issue: suppl 1
  year: 1999
  ident: 10.1136/ard.2006.061937_bib186
  article-title: Etanercept: therapeutic use in patients with rheumatoid arthritis.
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.58.2008.i65
– volume: 54
  start-page: 433
  year: 2005
  ident: 10.1136/ard.2006.061937_bib194
  article-title: Infections in RA patients treated with infliximab or etanercept [abstract].
  publication-title: Ann Rheum Dis
– volume: 130
  start-page: 478
  year: 1999
  ident: 10.1136/ard.2006.061937_bib32
  article-title: Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial.
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-130-6-199903160-00004
– volume: 52
  start-page: 3279
  year: 2005
  ident: 10.1136/ard.2006.061937_bib55
  article-title: Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: results of a double-blind, randomized, placebo-controlled trial.
  publication-title: Arthritis Rheum
  doi: 10.1002/art.21306
– volume: 46
  start-page: s169
  year: 2004
  ident: 10.1136/ard.2006.061937_bib187
  article-title: Coccidiomycosis (Valley Fever) occurring during infliximab therapy [abstract].
  publication-title: Arthritis Rheum
– volume: 21
  start-page: 526
  year: 2003
  ident: 10.1136/ard.2006.061937_bib189
  article-title: Mycobacteria tuberculosis peritonitis associated with etanercept therapy.
  publication-title: Clin Exp Rheumatol
– volume: 63
  start-page: 156
  year: 2004
  ident: 10.1136/ard.2006.061937_bib45
  article-title: Treatment of refractory psoriatic arthritis with infliximab: a 12 month observational study of 16 patients.
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.2003.006775
– volume: 46
  start-page: S358
  issue: suppl
  year: 2002
  ident: 10.1136/ard.2006.061937_bib211
  article-title: TNF-Alpha antagonists induce lupus-like syndrome in patients with scleroderma and polyarthritis [abstract].
  publication-title: Arthritis Rheum
– volume: 46
  start-page: 2565
  year: 2002
  ident: 10.1136/ard.2006.061937_bib188
  article-title: Life-threatening histoplasmosis complicating immunotherapy with tumor necrosis factor alpha antagonists infliximab and etanercept.
  publication-title: Arthritis Rheum
  doi: 10.1002/art.10583
– volume: 318
  start-page: 593
  year: 1999
  ident: 10.1136/ard.2006.061937_bib2
  article-title: Clinical guidelines: developing guidelines.
  publication-title: BMJ
  doi: 10.1136/bmj.318.7183.593
– volume: 2
  start-page: 542
  year: 2004
  ident: 10.1136/ard.2006.061937_bib215
  article-title: Incidence and importance of antibody responses to infliximab after maintenance or episodic treatment in Crohn's disease.
  publication-title: Clin Gastroenterol Hepatol
  doi: 10.1016/S1542-3565(04)00238-1
– volume: 44
  start-page: S403
  issue: suppl
  year: 2000
  ident: 10.1136/ard.2006.061937_bib66
  article-title: Anti-TNF alpha treatment of patients with severe anklyosing spondylitis—a one year follow-up [abstract].
  publication-title: Arthritis Rheum
– volume: 30
  start-page: 1864
  year: 2003
  ident: 10.1136/ard.2006.061937_bib148
  article-title: Etanercept ameliorates sarcoidosis arthritis and skin disease.
  publication-title: J Rheumatol
– volume: 54
  start-page: 678
  year: 2006
  ident: 10.1136/ard.2006.061937_bib172
  article-title: Adalimumab reduces spinal symptoms in active ankylosing spondylitis: clinical and magnetic resonance imaging results of a fifty-two-week open-label trial.
  publication-title: Arthritis Rheum
  doi: 10.1002/art.21563
– volume: 50
  start-page: 3432
  year: 2004
  ident: 10.1136/ard.2006.061937_bib38
  article-title: Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial.
  publication-title: Arthritis Rheum
  doi: 10.1002/art.20568
– volume: 110
  start-page: 1449
  year: 2003
  ident: 10.1136/ard.2006.061937_bib160
  article-title: Infliximab in the treatment of refractory posterior uveitis.
  publication-title: Ophthalmology
  doi: 10.1016/S0161-6420(03)00406-8
– volume: 345
  start-page: 1098
  year: 2001
  ident: 10.1136/ard.2006.061937_bib185
  article-title: Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent.
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa011110
– volume: 46
  start-page: 2287
  year: 2002
  ident: 10.1136/ard.2006.061937_bib191
  article-title: Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study.
  publication-title: Arthritis Rheum
  doi: 10.1002/art.10524
– volume: 76
  start-page: 1733
  year: 2005
  ident: 10.1136/ard.2006.061937_bib100
  article-title: Efficacy of TNF {alpha} blockade in cyclophosphamide resistant neuro-Behcet disease.
  publication-title: J Neurol Neurosurg Psychiatry
  doi: 10.1136/jnnp.2004.055434
– volume: 26
  start-page: 243
  year: 2004
  ident: 10.1136/ard.2006.061937_bib156
  article-title: Lupus nephritis improvement after anti-tumor necrosis factor alpha monoclonal antibody (infliximab) treatment for Crohn's disease: a case report.
  publication-title: Immunopharmacol Immunotoxicol
  doi: 10.1081/IPH-120037721
– volume: 48
  issue: Suppl 9
  year: 2003
  ident: 10.1136/ard.2006.061937_bib217
  article-title: Markenson JA. Granulomatous infections and tumor necrosis factor antagonist therapies: update through June 2002 [abstract].
  publication-title: Arthritis Rheum
– volume: 46
  start-page: 1470
  year: 2002
  ident: 10.1136/ard.2006.061937_bib245
  article-title: Costimulatory blockade in patients with rheumatoid arthritis: a pilot, dose-finding, double-blind, placebo-controlled clinical trial evaluating CTLA-4Ig and LEA29Y eighty-five days after the first infusion.
  publication-title: Arthritis Rheum
  doi: 10.1002/art.10294
– volume: 172
  start-page: 1935
  year: 2004
  ident: 10.1136/ard.2006.061937_bib17
  publication-title: J Immunol
  doi: 10.4049/jimmunol.172.3.1935
– volume: 57
  start-page: 945
  year: 1999
  ident: 10.1136/ard.2006.061937_bib23
  article-title: Etanercept: a review of its use in rheumatoid arthritis.
  publication-title: Drugs
  doi: 10.2165/00003495-199957060-00014
– volume: 48
  start-page: 218
  year: 2003
  ident: 10.1136/ard.2006.061937_bib29
  article-title: Long-term efficacy and safety of etanercept in children with polyarticular-course juvenile rheumatoid arthritis: interim results from an ongoing multicenter, open-label, extended-treatment trial.
  publication-title: Arthritis Rheum
  doi: 10.1002/art.10710
– volume: 39
  start-page: 1390
  year: 2004
  ident: 10.1136/ard.2006.061937_bib103
  article-title: A double-blind randomized controlled trial of infliximab associated with prednisolone in acute alcoholic hepatitis.
  publication-title: Hepatology
  doi: 10.1002/hep.20206
– volume: 64
  start-page: 699
  year: 2005
  ident: 10.1136/ard.2006.061937_bib197
  article-title: TNF blockers do not increase overall tumour risk in patients with rheumatoid arthritis, but may be associated with increased risk of lymphomas.
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.2004.030528
– volume: 44
  start-page: S90
  issue: suppl
  year: 2001
  ident: 10.1136/ard.2006.061937_bib115
  article-title: Successful use of infliximab in a case of refractory juvenile dermatomyositis [abstract].
  publication-title: Arthritis Rheum
– ident: 10.1136/ard.2006.061937_bib61
– volume: 51
  start-page: 580
  year: 2004
  ident: 10.1136/ard.2006.061937_bib128
  article-title: Etanercept therapy for patients with psoriatic arthritis and concurrent hepatitis C virus infection: report of 3 cases.
  publication-title: J Am Acad Dermatol
  doi: 10.1016/j.jaad.2004.05.013
– volume: 46
  start-page: S306
  issue: suppl
  year: 2002
  ident: 10.1136/ard.2006.061937_bib113
  article-title: Use of etanercept in juvenile dermatomyositis [abstract].
  publication-title: Arthritis Rheum
– volume: 100
  start-page: 3479
  year: 2002
  ident: 10.1136/ard.2006.061937_bib241
  article-title: Interleukin-1 blockade does not prevent acute graft-versus-host disease: results of a randomized, double-blind, placebo-controlled trial of interleukin-1 receptor antagonist in allogeneic bone marrow transplantation.
  publication-title: Blood
  doi: 10.1182/blood-2002-03-0985
– volume: 62
  start-page: 1116
  year: 2003
  ident: 10.1136/ard.2006.061937_bib119
  article-title: Experience with infliximab (anti-TNF alpha monoclonal antibody) as monotherapy for giant cell arteritis.
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.62.11.1116
– volume: 22
  start-page: 227
  year: 2002
  ident: 10.1136/ard.2006.061937_bib44
  article-title: Treatment of psoriatic arthritis and psoriasis vulgaris with the tumor necrosis factor inhibitor infliximab.
  publication-title: Rheumatol Int
  doi: 10.1007/s00296-002-0246-3
– volume: 39
  start-page: 295
  year: 2004
  ident: 10.1136/ard.2006.061937_bib181
  article-title: Tuberculosis following the use of etanercept, a tumor necrosis factor inhibitor
  publication-title: Clin Infect Dis
  doi: 10.1086/421494
– volume: 48
  start-page: S439
  year: 2003
  ident: 10.1136/ard.2006.061937_bib255
  article-title: Sustained efficacy at 48 weeks after single treatment course of rituximab in patients with rheumatoid arthritis [abstract].
  publication-title: Arthritis Rheum
– volume: 63
  start-page: 508
  year: 2004
  ident: 10.1136/ard.2006.061937_bib33
  article-title: Efficacy and safety of adalimumab as monotherapy in patients for whom previous DMARD treatment has failed.
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.2003.013052
– volume: 8
  start-page: 1
  year: 2003
  ident: 10.1136/ard.2006.061937_bib43
  article-title: Etanercept, a TNF antagonist for treatment for psoriatic arthritis and psoriasis.
  publication-title: Skin Therapy Lett
– volume: 32
  start-page: 1374
  year: 2005
  ident: 10.1136/ard.2006.061937_bib137
  article-title: Treatment of orbital myositis with adalimumab (Humira).
  publication-title: J Rheumatol
– volume: 25
  start-page: 596
  year: 2006
  ident: 10.1136/ard.2006.061937_bib142
  article-title: Treatment of therapy-resistant sarcoidosis with adalimumab.
  publication-title: Clin Rheumatol
  doi: 10.1007/s10067-005-0037-9
– volume: 50
  start-page: 2296
  year: 2004
  ident: 10.1136/ard.2006.061937_bib157
  article-title: Anti-tumor necrosis factor therapy in patients with difficult to treat Takayasu arteritis.
  publication-title: Arthritis Rheum
  doi: 10.1002/art.20300
– volume: 52
  start-page: 263
  year: 2005
  ident: 10.1136/ard.2006.061937_bib258
  article-title: Safety and tolerability of rituximab in patients with moderate to severe rheumatoid arthritis (RA): results from the Dose-ranging Assessment International Clinical Evaluation of Rituximab in RA (DANCER) study.
  publication-title: Arthritis Rheum
– volume: 46
  start-page: S206
  issue: suppl
  year: 2002
  ident: 10.1136/ard.2006.061937_bib95
  article-title: Etanercept is beneficial in controlling the mucocutaneous lesions of Bechet's syndrome [abstract].
  publication-title: Arthritis Rheum
– volume: 50
  start-page: 1270
  year: 2004
  ident: 10.1136/ard.2006.061937_bib78
  article-title: Inefficacy of infliximab in primary Sjogren's syndrome: results of the randomized, controlled Trial of Remicade in Primary Sjogren's Syndrome (TRIPSS).
  publication-title: Arthritis Rheum
  doi: 10.1002/art.20146
– volume: 358
  start-page: 295
  year: 2001
  ident: 10.1136/ard.2006.061937_bib98
  article-title: Effect of infliximab on sight-threatening panuveitis in Behcet's disease.
  publication-title: Lancet
  doi: 10.1016/S0140-6736(01)05497-6
– volume: 46
  start-page: S71
  issue: suppl
  year: 2002
  ident: 10.1136/ard.2006.061937_bib87
  article-title: Treatment of secondary amyloidosis with infliximab [abstract].
  publication-title: Arthritis Rheum
– volume: 357
  start-page: 1842
  year: 2001
  ident: 10.1136/ard.2006.061937_bib60
  article-title: Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial.
  publication-title: Lancet
  doi: 10.1016/S0140-6736(00)04954-0
– volume: 42
  start-page: 244
  year: 2003
  ident: 10.1136/ard.2006.061937_bib4
  article-title: A simplified disease activity index for rheumatoid arthritis for use in clinical practice.
  publication-title: Rheumatology (Oxford)
  doi: 10.1093/rheumatology/keg072
– volume: 63
  start-page: 149
  year: 2004
  ident: 10.1136/ard.2006.061937_bib13
  article-title: Infliximab in active early rheumatoid arthritis.
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.2003.013961
– volume: 133
  start-page: 753
  year: 2000
  ident: 10.1136/ard.2006.061937_bib134
  article-title: Treatment of myelodysplasia in a patient with active rheumatoid arthritis.
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-133-9-200011070-00037
– volume: 48
  start-page: 1
  year: 1999
  ident: 10.1136/ard.2006.061937_bib24
  article-title: Tumor necrosis factor inhibitors for rheumatoid arthritis.
  publication-title: Bull Rheum Dis
– volume: 81
  start-page: 349
  year: 2002
  ident: 10.1136/ard.2006.061937_bib159
  article-title: The TNF receptor-associated periodic syndrome (TRAPS): emerging concepts of an autoinflammatory disorder.
  publication-title: Medicine (Baltimore)
  doi: 10.1097/00005792-200209000-00002
– volume: 22
  start-page: 756
  year: 2004
  ident: 10.1136/ard.2006.061937_bib214
  article-title: Induction of autoantibodies in refractory rheumatoid arthritis treated by infliximab.
  publication-title: Clin Exp Rheumatol
– volume: 62
  start-page: 829
  year: 2003
  ident: 10.1136/ard.2006.061937_bib68
  article-title: Systematic safety follow up in a cohort of 107 patients with spondyloarthropathy treated with infliximab: a new perspective on the role of host defence in the pathogenesis of the disease?
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.62.9.829
– volume: 27
  start-page: 307
  year: 2004
  ident: 10.1136/ard.2006.061937_bib180
  article-title: Safety of tumour necrosis factor-alpha antagonists.
  publication-title: Drug Saf
  doi: 10.2165/00002018-200427050-00003
– volume: 51
  start-page: 200
  year: 2004
  ident: 10.1136/ard.2006.061937_bib106
  article-title: Pilot study of etanercept in patients with relapsed cutaneous T-cell lymphomas.
  publication-title: J Am Acad Dermatol
  doi: 10.1016/j.jaad.2003.05.009
– volume: 33
  start-page: 283
  year: 2004
  ident: 10.1136/ard.2006.061937_bib192
  article-title: The effect of tumor necrosis factor blockade on the response to pneumococcal vaccination in patients with rheumatoid arthritis and ankylosing spondylitis.
  publication-title: Semin Arthritis Rheum
  doi: 10.1053/j.semarthrit.2003.10.003
– volume: 43
  start-page: 852
  year: 2004
  ident: 10.1136/ard.2006.061937_bib109
  article-title: Generalized necrobiosis lipoidica treated with a combination of split-thickness autografting and immunomodulatory therapy
  publication-title: Int J Dermatol
  doi: 10.1111/j.1365-4632.2004.02120.x
– volume: 99
  start-page: 2385
  year: 2004
  ident: 10.1136/ard.2006.061937_bib208
  article-title: Outcome of pregnancy in women receiving infliximab for the treatment of Crohn's disease and rheumatoid arthritis.
  publication-title: Am J Gastroenterol
  doi: 10.1111/j.1572-0241.2004.30186.x
– volume: 317
  start-page: 180
  year: 1998
  ident: 10.1136/ard.2006.061937_bib196
  article-title: Disease activity and risk of lymphoma in patients with rheumatoid arthritis: nested case-control study.
  publication-title: BMJ
  doi: 10.1136/bmj.317.7152.180
– volume: 63
  start-page: 1041
  year: 2004
  ident: 10.1136/ard.2006.061937_bib234
  article-title: Efficacy of anakinra in active ankylosing spondylitis: a clinical and magnetic resonance imaging study.
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.2004.020800
– volume: 64
  start-page: 647
  year: 2005
  ident: 10.1136/ard.2006.061937_bib227
  article-title: Refractory adult onset Still's disease successfully treated with anakinra.
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.2004.026617
– volume: 350
  start-page: 2572
  year: 2004
  ident: 10.1136/ard.2006.061937_bib249
  article-title: Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis.
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa032534
– volume: 38
  start-page: 1261
  year: 2004
  ident: 10.1136/ard.2006.061937_bib182
  article-title: Granulomatous infectious diseases associated with tumor necrosis factor antagonists.
  publication-title: Clin Infect Dis
  doi: 10.1086/383317
– volume: 344
  start-page: 1125
  year: 1994
  ident: 10.1136/ard.2006.061937_bib19
  article-title: Repeated therapy with monoclonal antibody to tumour necrosis factor alpha (cA2) in patients with rheumatoid arthritis.
  publication-title: Lancet
  doi: 10.1016/S0140-6736(94)90632-7
– volume: 52
  start-page: 364
  year: 2005
  ident: 10.1136/ard.2006.061937_bib225
  article-title: Lack of response to anakinsa in RA following TNF alpha blockage: comment.
  publication-title: Arthritis Rheum
  doi: 10.1002/art.20769
– volume: 23
  start-page: 1849
  year: 1996
  ident: 10.1136/ard.2006.061937_bib31
  article-title: Recombinant soluble tumor necrosis factor receptor (p80) fusion protein: toxicity and dose finding trial in refractory rheumatoid arthritis.
  publication-title: J Rheumatol
– volume: 24
  start-page: 593
  year: 1998
  ident: 10.1136/ard.2006.061937_bib25
  article-title: Anti-tumor necrosis factor-alpha monoclonal antibody therapy for rheumatoid arthritis.
  publication-title: Rheum Dis Clin North Am
  doi: 10.1016/S0889-857X(05)70028-4
– ident: 10.1136/ard.2006.061937_bib91
– volume: 64
  start-page: 403
  year: 2005
  ident: 10.1136/ard.2006.061937_bib213
  article-title: Autoantibody formation in patients with rheumatoid arthritis treated with anti-TNF alpha.
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.2004.024182
– volume: 60
  start-page: iii55
  issue: suppl 3
  year: 2001
  ident: 10.1136/ard.2006.061937_bib83
  article-title: Successful treatment of a small cohort of patients with adult onset of Still's disease with infliximab: first experiences.
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.60.90003.iii55
– volume: 144
  start-page: 587
  year: 2001
  ident: 10.1136/ard.2006.061937_bib48
  article-title: Treatment of psoriatic arthritis with antitumour necrosis factor-alpha antibody clears skin lesions of psoriasis resistant to treatment with methotrexate.
  publication-title: Br J Dermatol
  doi: 10.1046/j.1365-2133.2001.04089.x
– volume: 50
  start-page: 3161
  year: 2004
  ident: 10.1136/ard.2006.061937_bib154
  article-title: Safety and efficacy of tumor necrosis factor alpha blockade in systemic lupus erythematosus: an open-label study.
  publication-title: Arthritis Rheum
  doi: 10.1002/art.20576
– volume: 65
  start-page: 1006
  year: 2006
  ident: 10.1136/ard.2006.061937_bib224
  article-title: Safety of extended treatment with anakinra in patients with rheumatoid arthritis.
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.2005.048371
– volume: 40
  start-page: 205
  year: 2001
  ident: 10.1136/ard.2006.061937_bib259
  article-title: Sustained improvement in rheumatoid arthritis following a protocol designed to deplete B lymphocytes.
  publication-title: Rheumatology (Oxford)
  doi: 10.1093/rheumatology/40.2.205
– volume: 61
  start-page: 283
  year: 2002
  ident: 10.1136/ard.2006.061937_bib96
  article-title: Remission of Behcet's syndrome with TNFalpha blocking treatment.
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.61.3.283-a
– volume: 201
  start-page: 1479
  year: 2005
  ident: 10.1136/ard.2006.061937_bib238
  article-title: Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade.
  publication-title: J Exp Med
  doi: 10.1084/jem.20050473
– volume: 62
  start-page: 373
  year: 2003
  ident: 10.1136/ard.2006.061937_bib121
  article-title: Successful treatment of resistant giant cell arteritis with etanercept.
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.62.4.373
– volume: 52
  start-page: 27
  year: 2005
  ident: 10.1136/ard.2006.061937_bib175
  publication-title: Arthritis Rheum
  doi: 10.1002/art.20712
– volume: 37
  start-page: 448
  year: 2002
  ident: 10.1136/ard.2006.061937_bib104
  article-title: Combination of steroids with infliximab or placebo in severe alcoholic hepatitis: a randomized controlled pilot study.
  publication-title: J Hepatol
  doi: 10.1016/S0168-8278(02)00230-1
– volume: 46
  start-page: 1965
  year: 2002
  ident: 10.1136/ard.2006.061937_bib150
  article-title: Sustained response to tumor necrosis factor alpha-blocking agents in two patients with SAPHO syndrome.
  publication-title: Arthritis Rheum
  doi: 10.1002/art.10539
– volume: 48
  start-page: 319
  year: 2003
  ident: 10.1136/ard.2006.061937_bib193
  article-title: Listeria monocytogenes infection as a complication of treatment with tumor necrosis factor alpha-neutralizing agents.
  publication-title: Arthritis Rheum
  doi: 10.1002/art.10758
– volume: 117
  start-page: 208
  year: 2004
  ident: 10.1136/ard.2006.061937_bib232
  article-title: Beneficial response to interleukin 1 receptor antagonist in traps.
  publication-title: Am J Med
  doi: 10.1016/j.amjmed.2004.02.039
– volume: 42
  start-page: 315
  year: 2005
  ident: 10.1136/ard.2006.061937_bib75
  article-title: Etanercept as an adjuvant to interferon and ribavirin in treatment-naive patients with chronic hepatitis C virus infection: a phase 2 randomized, double-blind, placebo-controlled study.
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2004.11.025
– volume: 146
  start-page: 662
  year: 2005
  ident: 10.1136/ard.2006.061937_bib131
  article-title: Infliximab treatment for refractory Kawasaki syndrome.
  publication-title: J Pediatr
  doi: 10.1016/j.jpeds.2004.12.022
– volume: 31
  start-page: 107
  year: 2004
  ident: 10.1136/ard.2006.061937_bib204
  article-title: Infliximab therapy for rheumatic diseases in patients with chronic hepatitis B or C.
  publication-title: J Rheumatol
– volume: 53
  start-page: 18
  year: 2005
  ident: 10.1136/ard.2006.061937_bib161
  article-title: A randomized, placebo-controlled, double-masked clinical trial of etanercept for the treatment of uveitis associated with juvenile idiopathic arthritis.
  publication-title: Arthritis Rheum
  doi: 10.1002/art.20904
– ident: 10.1136/ard.2006.061937_bib239
– volume: 64
  start-page: 432
  issue: suppl 3
  year: 2005
  ident: 10.1136/ard.2006.061937_bib257
  article-title: Safety and tolerability of rituximab in patients with moderate to severe rheumatoid arthritis (RA): results from the Dose-ranging Assessment iNternational Clinical Evaluation of Rituximab in RA (DANCER) study [abstract].
  publication-title: Ann Rheum Dis
– volume: 27
  start-page: 376
  year: 1984
  ident: 10.1136/ard.2006.061937_bib54
  article-title: Randomized, double-blind, placebo controlled trial of low-dose pulse methotrexate in psoriatic arthritis.
  publication-title: Arthritis Rheum
  doi: 10.1002/art.1780270403
– volume: 349
  start-page: 2014
  year: 2003
  ident: 10.1136/ard.2006.061937_bib62
  article-title: Etanercept as monotherapy in patients with psoriasis.
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa030409
– volume: 40
  start-page: 937
  year: 2002
  ident: 10.1136/ard.2006.061937_bib206
  article-title: [Gastrointestinal side effects in the therapy of rheumatologic diseases].
  publication-title: Z Gastroenterol
  doi: 10.1055/s-2002-35412
– volume: 13
  start-page: 589
  year: 1995
  ident: 10.1136/ard.2006.061937_bib53
  article-title: Comparison of cyclosporin A and methotrexate in the treatment of psoriatic arthritis: a one-year prospective study.
  publication-title: Clin Exp Rheumatol
– volume: 64
  start-page: 320
  issue: suppl III
  year: 2005
  ident: 10.1136/ard.2006.061937_bib176
  article-title: Adalimumab treatment effects on radiographic progression of joint disease in patients with psoriatic arthritis: results from ADEPT [abstract].
  publication-title: Ann Rheum Dis
– volume: 90
  start-page: 711
  year: 1991
  ident: 10.1136/ard.2006.061937_bib219
  article-title: Methotrexate and histologic hepatic abnormalities: a meta-analysis.
  publication-title: Am J Med
  doi: 10.1016/0002-9343(91)90667-M
– volume: 141
  start-page: 1167
  year: 2005
  ident: 10.1136/ard.2006.061937_bib132
  article-title: Etanercept and the treatment of multicentric reticulohistiocytosis.
  publication-title: Arch Dermatol
  doi: 10.1001/archderm.141.9.1167-b
– volume: 46
  start-page: S205
  issue: suppl
  year: 2002
  ident: 10.1136/ard.2006.061937_bib174
  article-title: Adalimumab, a fully human anti-TNF-alpha monoclonal antibody, inhibits the progression of structural joint damage in patients with active RA despite concomitant methotrexate therapy [abstract].
  publication-title: Arthritis Rheum
– volume: 46
  start-page: S168
  issue: suppl
  year: 2002
  ident: 10.1136/ard.2006.061937_bib210
  article-title: Induction of serological lupus in patients on leflunomide and infliximab [abstract].
  publication-title: Arthritis Rheum
– volume: 53
  start-page: S94
  year: 2005
  ident: 10.1136/ard.2006.061937_bib63
  article-title: Psoriasis—recent advances in its pathogenesis and treatment.
  publication-title: J Am Acad Dermatol
  doi: 10.1016/j.jaad.2005.04.035
– volume: 52
  start-page: 1283
  year: 2005
  ident: 10.1136/ard.2006.061937_bib229
  article-title: Interleukin-1 blockade by anakinra improves clinical symptoms in patients with neonatal-onset multisystem inflammatory disease.
  publication-title: Arthritis Rheum
  doi: 10.1002/art.20953
– volume: 359
  start-page: 1187
  year: 2002
  ident: 10.1136/ard.2006.061937_bib7
  article-title: Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial.
  publication-title: Lancet
  doi: 10.1016/S0140-6736(02)08215-6
– volume: 46
  start-page: 755
  year: 2002
  ident: 10.1136/ard.2006.061937_bib10
  article-title: Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor alpha (infliximab) versus placebo in active spondyloarthropathy.
  publication-title: Arthritis Rheum
  doi: 10.1002/art.511
– volume: 53
  start-page: 683
  year: 2004
  ident: 10.1136/ard.2006.061937_bib184
  article-title: Tuberculosis associated with blocking agents against tumor necrosis factor-alpha—California, 2002–2003.
  publication-title: MMWR Morb Mortal Wkly Rep
– volume: 144
  start-page: 597
  year: 2001
  ident: 10.1136/ard.2006.061937_bib129
  article-title: Common variable immunodeficiency treated with a recombinant human IgG, tumour necrosis factor-alpha receptor fusion protein
  publication-title: Br J Dermatol
  doi: 10.1046/j.1365-2133.2001.04092.x
– volume: 58
  start-page: i61
  issue: suppl 1
  year: 1999
  ident: 10.1136/ard.2006.061937_bib22
  article-title: Summary of clinical trials in rheumatoid arthritis using infliximab, an anti-TNFalpha treatment
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.58.2008.i61
– volume: 76
  start-page: 129
  year: 2005
  ident: 10.1136/ard.2006.061937_bib90
  article-title: Treatment of severe, recalcitrant, major aphthous stomatitis with adalimumab
  publication-title: Cutis
– volume: 32
  start-page: 98
  year: 2005
  ident: 10.1136/ard.2006.061937_bib76
  article-title: Short-term trial of etanercept in Behcet's disease: a double blind, placebo controlled study.
  publication-title: J Rheumatol
– volume: 44
  start-page: 2933
  year: 2001
  ident: 10.1136/ard.2006.061937_bib120
  article-title: Treatment of longstanding active giant cell arteritis with infliximab: report of four cases.
  publication-title: Arthritis Rheum
  doi: 10.1002/1529-0131(200112)44:12<2933::AID-ART482>3.0.CO;2-Y
– volume: 39
  start-page: 1254
  year: 2004
  ident: 10.1136/ard.2006.061937_bib183
  article-title: Broder M, Wong J, Beenhouwer D. Granulomatous infections due to tumor necrosis factor blockade: correction,
  publication-title: Clin Infect Dis
  doi: 10.1086/424455
– volume: 25
  start-page: 1115
  year: 1997
  ident: 10.1136/ard.2006.061937_bib240
  article-title: Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group.
  publication-title: Crit Care Med
  doi: 10.1097/00003246-199707000-00010
– ident: 10.1136/ard.2006.061937_bib14
– volume: 46
  start-page: S170
  issue: suppl
  year: 2002
  ident: 10.1136/ard.2006.061937_bib139
  article-title: Infliximab in the treatment of polychondritis [abstract].
  publication-title: Arthritis Rheum
– volume: 143
  start-page: 918
  year: 2005
  ident: 10.1136/ard.2006.061937_bib152
  article-title: Tumor necrosis factor-alpha inhibitor therapy in erosive polyarthritis secondary to systemic sclerosis.
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-143-12-200512200-00019
– volume: 63
  start-page: 426
  year: 2004
  ident: 10.1136/ard.2006.061937_bib173
  article-title: Dose escalation of infliximab in clinical practice: improvements seen may be explained by a regression-like effect.
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.2003.010967
– volume: 120
  start-page: 995
  year: 2001
  ident: 10.1136/ard.2006.061937_bib93
  article-title: Anti-tumor necrosis factor monoclonal antibody therapy for gastrointestinal Behcet's disease: a case report.
  publication-title: Gastroenterology
  doi: 10.1053/gast.2001.22556
– volume: 62
  start-page: 817
  year: 2003
  ident: 10.1136/ard.2006.061937_bib65
  article-title: International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitis.
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.62.9.817
– volume: 52
  start-page: 42
  year: 2005
  ident: 10.1136/ard.2006.061937_bib171
  article-title: C-reactive protein as a predictor of infliximab treatment outcome in patients with rheumatoid arthritis: defining subtypes of nonresponse and subsequent response to etanercept.
  publication-title: Arthritis Rheum
  doi: 10.1002/art.20711
– volume: 50
  start-page: 2240
  year: 2004
  ident: 10.1136/ard.2006.061937_bib79
  article-title: Etanercept in Sjogren's syndrome: a twelve-week randomized, double-blind, placebo-controlled pilot clinical trial.
  publication-title: Arthritis Rheum
  doi: 10.1002/art.20299
– volume: 46
  start-page: 1443
  year: 2002
  ident: 10.1136/ard.2006.061937_bib37
  article-title: Etanercept versus methotrexate in patients with early rheumatoid arthritis: two-year radiographic and clinical outcomes.
  publication-title: Arthritis Rheum
  doi: 10.1002/art.10308
– volume: 348
  start-page: 601
  year: 2003
  ident: 10.1136/ard.2006.061937_bib74
  article-title: Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease.
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa020888
– volume: 49
  start-page: 599
  year: 2003
  ident: 10.1136/ard.2006.061937_bib97
  article-title: Treatment with infliximab for a child with Behcet's disease.
  publication-title: Arthritis Rheum
  doi: 10.1002/art.11204
– volume: 48
  start-page: 864
  year: 2003
  ident: 10.1136/ard.2006.061937_bib133
  article-title: Multicentric reticulohistiocytosis treated successfully with an anti-tumor necrosis factor agent: comment on the article by Gorman et al
  publication-title: Arthritis Rheum
  doi: 10.1002/art.10781
– volume: 38
  start-page: 618
  year: 1995
  ident: 10.1136/ard.2006.061937_bib51
  article-title: Sulfasalazine in the treatment of spondyloarthropathy. A randomized, multicenter, double-blind, placebo-controlled study.
  publication-title: Arthritis Rheum
  doi: 10.1002/art.1780380507
– volume: 44
  start-page: 2371
  year: 2001
  ident: 10.1136/ard.2006.061937_bib77
  article-title: Infliximab in patients with primary Sjogren's syndrome: a pilot study.
  publication-title: Arthritis Rheum
  doi: 10.1002/1529-0131(200110)44:10<2371::AID-ART401>3.0.CO;2-W
– volume: 64
  start-page: 60
  year: 2005
  ident: 10.1136/ard.2006.061937_bib195
  article-title: Safety of abatacept in patients with active rheumatoid arthritis receiving background non-biologic DMARDs: 1 year results of the ASSURE Trial.
  publication-title: Ann Rheum Dis
– volume: 52
  issue: suppl
  year: 2005
  ident: 10.1136/ard.2006.061937_bib199
  article-title: Use of anti-TNF alpha drugs and incidence of hematologic and solid cancers in patients with rheumatoid arthritis [abstract].
  publication-title: Arthritis Rheum
– volume: 4
  start-page: 19
  year: 2003
  ident: 10.1136/ard.2006.061937_bib92
  article-title: Remission of Behcet's disease with anti-tumor necrosis factor monoclonal antibody therapy: a case report.
  publication-title: BMC Musculoskelet Disord
  doi: 10.1186/1471-2474-4-19
– volume: 41
  start-page: s208
  issue: suppl 3
  year: 2005
  ident: 10.1136/ard.2006.061937_bib190
  article-title: TNF inhibitors and invasive fungal infections.
  publication-title: Clin Infect Dis
  doi: 10.1086/430000
– volume: 44
  start-page: S152
  issue: suppl
  year: 2001
  ident: 10.1136/ard.2006.061937_bib207
  article-title: Outcome of pregnancy in women receiving infliximab for the treatment of Crohn's disease or rheumatoid arthritis [abstract].
  publication-title: Arthritis Rheum
– volume: 52
  start-page: 280
  year: 2005
  ident: 10.1136/ard.2006.061937_bib107
  article-title: Successful treatment of psoriatic onycho-pachydermo periostitis (POPP) with adalimumab.
  publication-title: Arthritis Rheum
  doi: 10.1002/art.20763
– volume: 86
  start-page: 123
  year: 2002
  ident: 10.1136/ard.2006.061937_bib140
  article-title: How to RECOVER from RENAISSANCE? The significance of the results of RECOVER, RENAISSANCE, RENEWAL and ATTACH
  publication-title: Int J Cardiol
  doi: 10.1016/S0167-5273(02)00470-9
– volume: 6
  start-page: 1
  year: 2002
  ident: 10.1136/ard.2006.061937_bib16
  article-title: A systematic review of effectiveness and economic evaluation of new drug treatments for juvenile idiopathic arthritis: etanercept.
  publication-title: Health Technol Assess
  doi: 10.3310/phr06120
– volume: 20
  start-page: 1075
  year: 2004
  ident: 10.1136/ard.2006.061937_bib147
  article-title: Efficacy of etanercept delivered by perispinal administration for chronic back and/or neck disc-related pain: a study of clinical observations in 143 patients.
  publication-title: Curr Med Res Opin
  doi: 10.1185/030079903125004286
– volume: 52
  start-page: 1794
  year: 2005
  ident: 10.1136/ard.2006.061937_bib226
  article-title: Rapid responses to anakinra in patients with refractory adult-onset Still's disease.
  publication-title: Arthritis Rheum
  doi: 10.1002/art.21061
– volume: 145
  start-page: 851
  year: 2004
  ident: 10.1136/ard.2006.061937_bib108
  article-title: Abnormal production of tumor necrosis factor (TNF)—alpha and clinical efficacy of the TNF inhibitor etanercept in a patient with PAPA syndrome [corrected].
  publication-title: J Pediatr
  doi: 10.1016/j.jpeds.2004.08.001
– volume: 353
  start-page: 1114
  year: 2005
  ident: 10.1136/ard.2006.061937_bib242
  article-title: Abatacept for rheumatoid arthritis refractory to tumor necrosis factor alpha inhibition.
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa050524
– volume: 43
  start-page: 128
  year: 1984
  ident: 10.1136/ard.2006.061937_bib198
  article-title: Cancer morbidity in rheumatoid arthritis.
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.43.2.128
– ident: 10.1136/ard.2006.061937_bib70
– volume: 48
  start-page: 2645
  year: 2003
  ident: 10.1136/ard.2006.061937_bib117
  article-title: Favorable preliminary experience with etanercept in two patients with the hyperimmunoglobulinemia D and periodic fever syndrome.
  publication-title: Arthritis Rheum
  doi: 10.1002/art.11218
– volume: 41
  start-page: 1552
  year: 1998
  ident: 10.1136/ard.2006.061937_bib36
  article-title: Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis.
  publication-title: Arthritis Rheum
  doi: 10.1002/1529-0131(199809)41:9<1552::AID-ART5>3.0.CO;2-W
– volume: 1
  start-page: 333
  year: 2004
  ident: 10.1136/ard.2006.061937_bib223
  article-title: Anakinra: an inhibitor of IL-1 for the treatment of rheumatoid arthritis.
  publication-title: Expert Opin Biol Ther
– volume: 47
  start-page: 506
  year: 2002
  ident: 10.1136/ard.2006.061937_bib42
  article-title: Open-label study of infliximab treatment for psoriatic arthritis: clinical and magnetic resonance imaging measurements of reduction of inflammation.
  publication-title: Arthritis Rheum
  doi: 10.1002/art.10671
SSID ssj0000818
Score 2.1725469
Snippet Additional information has come to light in the past year, both corroborating the major positive effect these drugs have had in rheumatoid arthritis (RA),...
SourceID pubmedcentral
proquest
pubmed
pascalfrancis
crossref
istex
bmj
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage iii2
SubjectTerms Abatacept
ACR
American College of Rheumatology
ankylosing spondylitis
Antirheumatic Agents - adverse effects
Antirheumatic Agents - therapeutic use
Arthritis, Psoriatic - drug therapy
Arthritis, Rheumatoid - drug therapy
Biological and medical sciences
CHF
Clinical medicine
congestive heart failure
Consensus Statement
DAS
Disease
Disease Activity Score
disease modifying antirheumatic drug
Diseases of the osteoarticular system
DMARD
Drug dosages
guideline
HAQ-DI
Health Assessment Questionnaire disability index
Humans
IL-1ra
immunity
Immunization
Immunoconjugates - adverse effects
Immunoconjugates - therapeutic use
Immunologic Factors - adverse effects
Immunologic Factors - therapeutic use
Infections
inflammation
Interleukin 1 Receptor Antagonist Protein - adverse effects
Interleukin 1 Receptor Antagonist Protein - therapeutic use
Medical Outcome Survey Short Form 36
Medical sciences
methotrexate
Miscellaneous. Osteoarticular involvement in other diseases
MTX
Pain
Patients
Pharmaceutical industry
PsA
psoriatic arthritis
Rheumatic diseases
Rheumatic Diseases - drug therapy
rheumatoid arthritis
rituximab
SF-36
Spondylitis, Ankylosing - drug therapy
Studies
TNF
TNF blocking
TNF inhibitors
Tumor Necrosis Factor-alpha - antagonists & inhibitors
Tumor necrosis factor-TNF
tumour necrosis factor
VAS
visual analogue scale
Title Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2006
URI http://ard.bmj.com/content/65/suppl_3/iii2.full
https://api.istex.fr/ark:/67375/NVC-X55P7VJQ-X/fulltext.pdf
https://www.ncbi.nlm.nih.gov/pubmed/17038465
https://www.proquest.com/docview/1777852006
https://www.proquest.com/docview/68959068
https://pubmed.ncbi.nlm.nih.gov/PMC1798383
Volume 65
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1Lb9QwEB51uxLigng3UBZLIMSB0Dxt54AQVK2qSl0VxFZ7wnLsWAXaZNnsSvx8ZvJaFvE4O7aSmfHkG8_4G4DnwhkrAi79gGOkk2ie-Job41tOpxYmS_KGSPtsyk9myek8ne_AtL8LQ2WVvU9sHLWtDJ2RH4RCCEkcQfzt4rtPXaMou9q30NBdawX7pqEYG8EYXbJEux-_P5qef9z4ZhnKvodeknHRkf2EMT9AhXS5CYwpqC36KL_-uvW3GpPgf1D1pK5RgK7tfPEnaPp7heUvv6zj23Crw5rsXWscd2CnKO_CjbMum34PPs8WFO9bZqikuqzXNWvuF9GBIatK1hI0kRaZphtYNUOEyxAxsqE8nVWOLS-LdUP8yrpsT_2K0Sfeh9nx0afDE7_rt-DniMJWvnNRUKQcIyBpwkiILA8lD63LEpsjTCysDR0X6ARMkhvcx05qYyUGcUkUFU7H8QPYLauy2AMmbWEQa2ZBZF1i4lSHzuWCqOA5d1ZoD56hdNWiZdRQTSQSc4U6oL6YXLU68OB1L31lOspy6pxx9fcJL4cJ_137RaPO4Tm9_EZFbiJV04tDNU_Tc3Fx-kHNPZhs6XuzsIwSGfLAg_3eAFTnAGq1MVcPng7DuHUpH6PLolrXissMJcSlBw9ba9ksjX4YgWHqgdiyo-EBIgXfHim_XDbk4ERAF8v40b9f6jHcbM6SmkuV-7C7Wq6LJ4iuVvkERmIuJt3G-Qm7XiIq
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLZGKwEviDuBsVniIh4Ia1LHdh4mBGNTd2k10Dr1CePYscYtLU0r4M_x2zgncVqKuDztOYnV-hwff-f2HUIeCmes6HAZdjh4OkxzFmpuTGg5Ri1MyrKKSLs_4L0hOxglozXyo-mFwbLKxiZWhtqODcbItyIhhESOIP588iXEqVGYXW1GaGg_WsFuVxRjvrHjMP_-FVy4cnv_Fcj7URzv7Z7s9EI_ZSDMAHvMQufiTp5wwP3SRLEQaRZJHlmXMpsBOMqtjRwXoPqGZQa010ltrATXhcVx7jQGROEKaDPscG2R9svdwfGb5V0gI9nM7GMpF55cKOryLVAAnwsBHwbHsF_IPn9YuR3bKOhvWK2pSxCYqydt_AkK_17R-csVuXeVXPHYlr6olfEaWcuL6-Ri32fvb5C3wwnGFyw1WMJdlPOSVv1MGKCk44LWhFCoNVRjx1dJAVFTQKh0UQ5Px45Oz_J5RTRLfXapfErxL94kw3PZ-VukVYyL_A6h0uYGsG3aia1jppvoyLlMIPU8584KHZAHsLtqUjN4qMrz6XIFMsA5nFzVMgjIs2b3lfEU6Tip49PfP3iy-OC_az-uxLl4T08_YlGdSNTgdEeNkuRYnB68VqOAbKzIe7mwjJmMeCcg640CKG9wSrU8HgHZXDwGU4H5H13k43mpuExhh7gMyO1aW5ZLg90HIJoERKzo0eIFJCFffVK8P6vIyJHwriu7d__9ozbJpd5J_0gd7Q8O75HLVRyrauhcJ63ZdJ7fB2Q3yzb88aHk3Xmf2J-GFl3a
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Jb9NAFH4qrVRxQewYSjsSizhg4nVmfEAItURdaFQkUuXUwZ7xqGx2iBMBf41fx3veQhDLqWfbo2TeMt9b5nsAD4XVRnhcuh7HSCdKeeSmXGvXcMpa6CTKaiLt4xHfH0eHk3iyBj-6uzDUVtn5xNpRm1JTjnzgCyEkcQTxgW3bIk72hi-mX1yaIEWV1m6cRqMiR_n3rxi-Vc8P9lDWj4Jg-Ort7r7bThhwM8Qdc9fawMtjjphfaj8QIsl8yX1jk8hkCIxyY3zLBaq9jjKNmmtlqo3EsCUKgtymlAxF978hQkRVaEtiIpangPRlN60vSrhoaYX8kA9Q9G0VBKMXGsB-Kfv8YeVc3CARf6M-zbRCUdlmxsafQPDvvZy_HI7Dq3ClRbXsZaOG12AtL67D5nFbt78BZ-MpZRYM09S8XVSLitU3mSg1ycqCNVRQpC8spbteFUMszRCbsr4RnpWWzc7zRU0xy9q6UvWU0V-8CeML2fdbsF6URX4HmDS5RlSbeIGxkQ7j1Lc2E0Q6z7k1InXgAe6umjbcHaqOeUKuUAY0gZOrRgYOPOt2X-mWHJ1mdHz6-wdP-g_-u_bjWpz9e-nsI7XTiViNTnfVJI5PxOnhGzVxYHtF3suFZRBJn3sObHUKoFpXU6mlYTiw0z9GJ0GVn7TIy0WluExwh7h04HajLcul0eMjBI0dECt61L9A9OOrT4r35zUNOVHdhTK8--8ftQObaKfq9cHo6B5crhNY9U3OLVifzxb5fYR082y7th0G7y7aWH8C2cVbcA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=proceeding&rft.title=Annals+of+the+rheumatic+diseases&rft.atitle=Updated+consensus+statement+on+biological+agents+for+the+treatment+of+rheumatic+diseases%2C+2006&rft.au=FURST%2C+D.+E&rft.au=BREEDVELD%2C+F.+C&rft.au=WEISMAN%2C+M.+H&rft.au=KALDEN%2C+J.+R&rft.date=2006-11-01&rft.pub=BMJ&rft.issn=0003-4967&rft.volume=65&rft_id=info:doi/10.1136%2Fard.2006.061937&rft.externalDBID=n%2Fa&rft.externalDocID=18248160
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0003-4967&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0003-4967&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0003-4967&client=summon